
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs3.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="D0BD41E4AC192A4500004987612DAE3F.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="transmed" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC11157872/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157872/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Translational Medicine" /><meta name="citation_title" content="Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts" /><meta name="citation_author" content="Li Wei" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Qinying Huang" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Yunhai Tu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Shihan Song" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Xiaobo Zhang" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Bo Yu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Yufen Liu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Ziwei Li" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Qing Huang" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Lili Chen" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Bo Liu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Shenglan Xu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Tong Li" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Xiyuan Liu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Xiaozhou Hu" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Weijie Liu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Zai-Long Chi" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author" content="Wencan Wu" /><meta name="citation_author_institution" content="National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China" /><meta name="citation_author_institution" content="Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain health), Wenzhou, 32500 China" /><meta name="citation_publication_date" content="2024" /><meta name="citation_volume" content="22" /><meta name="citation_doi" content="10.1186/s12967-024-05263-y" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC11157872/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC11157872/" /><meta name="citation_pmid" content="38849907" /><meta name="DC.Title" content="Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BMC" /><meta name="DC.Contributor" content="Li Wei" /><meta name="DC.Contributor" content="Qinying Huang" /><meta name="DC.Contributor" content="Yunhai Tu" /><meta name="DC.Contributor" content="Shihan Song" /><meta name="DC.Contributor" content="Xiaobo Zhang" /><meta name="DC.Contributor" content="Bo Yu" /><meta name="DC.Contributor" content="Yufen Liu" /><meta name="DC.Contributor" content="Ziwei Li" /><meta name="DC.Contributor" content="Qing Huang" /><meta name="DC.Contributor" content="Lili Chen" /><meta name="DC.Contributor" content="Bo Liu" /><meta name="DC.Contributor" content="Shenglan Xu" /><meta name="DC.Contributor" content="Tong Li" /><meta name="DC.Contributor" content="Xiyuan Liu" /><meta name="DC.Contributor" content="Xiaozhou Hu" /><meta name="DC.Contributor" content="Weijie Liu" /><meta name="DC.Contributor" content="Zai-Long Chi" /><meta name="DC.Contributor" content="Wencan Wu" /><meta name="DC.Date" content="2024" /><meta name="DC.Identifier" content="10.1186/s12967-024-05263-y" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts" /><meta property="og:type" content="article" /><meta property="og:description" content="The pathogenesis of thyroid-associated orbitopathy (TAO) remains incompletely understand. The interaction between immunocytes and orbital fibroblasts (OFs) play a critical role in orbital inflammatory and fibrosis. Accumulating reports indicate that a ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157872/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11157872/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/214/">J Transl Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452086/">v.22; 2024</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11157872
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11157872/pdf/12967_2024_Article_5263.pdf" class="int-view">PDF (9.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11157872/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11157872/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11157872" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="4ZEK4HVkh20vg3GPbL6vElI49FUn0E3DaV3Rx7O7F7AZ8eIySrfDXBf5lp59H4fI">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F&amp;text=Plasma%20exosomes%20from%20patients%20with%20active%20thyroid-associated%20orbitopathy%20induce%20inflammation%20and%20fibrosis%20in%20orbital%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157872/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38849907/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38849907/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11157872/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/214/">J Transl Med</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452086/">v.22; 2024</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11157872
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-transmed.png" alt="Logo of transmed" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://translational-medicine.biomedcentral.com/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Transl Med.</span> 2024; 22: 546. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Jun 7. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1186%2Fs12967-024-05263-y" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/s12967-024-05263-y</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC11157872</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38849907">38849907</a></div></div></div><h1 class="content-title">Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20L%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697857890384" co-class="co-affbox">Li Wei</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20Q%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697845694176" co-class="co-affbox">Qinying Huang</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tu%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697848849600" co-class="co-affbox">Yunhai Tu</a>,<sup>#</sup><sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697848846752" co-class="co-affbox">Shihan Song</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20X%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697850419600" co-class="co-affbox">Xiaobo Zhang</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697850803424" co-class="co-affbox">Bo Yu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20Y%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697847559136" co-class="co-affbox">Yufen Liu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20Z%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697823998064" co-class="co-affbox">Ziwei Li</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20Q%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697823995344" co-class="co-affbox">Qing Huang</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20L%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697844791424" co-class="co-affbox">Lili Chen</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697835874704" co-class="co-affbox">Bo Liu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697852598512" co-class="co-affbox">Shenglan Xu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697852595792" co-class="co-affbox">Tong Li</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20X%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697854794560" co-class="co-affbox">Xiyuan Liu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hu%20X%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697839479520" co-class="co-affbox">Xiaozhou Hu</a>,<sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20W%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697841202112" co-class="co-affbox">Weijie Liu</a>,<sup>1,</sup><sup>2</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chi%20ZL%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697841199392" co-class="co-affbox">Zai-Long Chi</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20W%5BAuthor%5D" class="affpopup" co-rid="_co_idm140697841840352" co-class="co-affbox">Wencan Wu</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>2,</sup><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140697857890384"><h3 class="no_margin">Li Wei</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wei%20L%5BAuthor%5D">Li Wei</a></div></div><div id="_co_idm140697845694176"><h3 class="no_margin">Qinying Huang</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20Q%5BAuthor%5D">Qinying Huang</a></div></div><div id="_co_idm140697848849600"><h3 class="no_margin">Yunhai Tu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Tu%20Y%5BAuthor%5D">Yunhai Tu</a></div></div><div id="_co_idm140697848846752"><h3 class="no_margin">Shihan Song</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Song%20S%5BAuthor%5D">Shihan Song</a></div></div><div id="_co_idm140697850419600"><h3 class="no_margin">Xiaobo Zhang</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Zhang%20X%5BAuthor%5D">Xiaobo Zhang</a></div></div><div id="_co_idm140697850803424"><h3 class="no_margin">Bo Yu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yu%20B%5BAuthor%5D">Bo Yu</a></div></div><div id="_co_idm140697847559136"><h3 class="no_margin">Yufen Liu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20Y%5BAuthor%5D">Yufen Liu</a></div></div><div id="_co_idm140697823998064"><h3 class="no_margin">Ziwei Li</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20Z%5BAuthor%5D">Ziwei Li</a></div></div><div id="_co_idm140697823995344"><h3 class="no_margin">Qing Huang</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20Q%5BAuthor%5D">Qing Huang</a></div></div><div id="_co_idm140697844791424"><h3 class="no_margin">Lili Chen</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20L%5BAuthor%5D">Lili Chen</a></div></div><div id="_co_idm140697835874704"><h3 class="no_margin">Bo Liu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20B%5BAuthor%5D">Bo Liu</a></div></div><div id="_co_idm140697852598512"><h3 class="no_margin">Shenglan Xu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Xu%20S%5BAuthor%5D">Shenglan Xu</a></div></div><div id="_co_idm140697852595792"><h3 class="no_margin">Tong Li</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Li%20T%5BAuthor%5D">Tong Li</a></div></div><div id="_co_idm140697854794560"><h3 class="no_margin">Xiyuan Liu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20X%5BAuthor%5D">Xiyuan Liu</a></div></div><div id="_co_idm140697839479520"><h3 class="no_margin">Xiaozhou Hu</h3><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hu%20X%5BAuthor%5D">Xiaozhou Hu</a></div></div><div id="_co_idm140697841202112"><h3 class="no_margin">Weijie Liu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu%20W%5BAuthor%5D">Weijie Liu</a></div></div><div id="_co_idm140697841199392"><h3 class="no_margin">Zai-Long Chi</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chi%20ZL%5BAuthor%5D">Zai-Long Chi</a></div></div><div id="_co_idm140697841840352"><h3 class="no_margin">Wencan Wu</h3><p><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </p><p><sup>3</sup>Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain health), Wenzhou, 32500 China </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wu%20W%5BAuthor%5D">Wencan Wu</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140697849575296_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140697849575296_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140697849575296_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140697849575296_ai" style="display:none"><div class="fm-affl" id="Aff1"><sup>1</sup>National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </div><div class="fm-affl" id="Aff2"><sup>2</sup>State Key Laboratory of Ophthalmology, Optometry and Vison Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027 China </div><div class="fm-affl" id="Aff3"><sup>3</sup>Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain health), Wenzhou, 32500 China </div><div><span class="fm-affl">Zai-Long Chi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.ca.eye@ihc.gnoliaz" class="oemail">nc.ca.eye@ihc.gnoliaz</a></span>.</div><div><a href="#article-aaff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140697849575296_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2024 Jan 12; Accepted 2024 Apr 29.</div></div><div class="permissions half_rhythm hide" id="idm140697849575296_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2024</div><div class="license half_rhythm"><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="4" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 1</div><div><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">12967_2024_5263_MOESM1_ESM.docx</a><span style="color:gray"> (16K)</span></div><div class="small guid">GUID: 4D00B9C7-0827-4670-A354-8B9ADAA5B933</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 2</div><div><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM2_ESM.docx" data-ga-action="click_feat_suppl">12967_2024_5263_MOESM2_ESM.docx</a><span style="color:gray"> (31K)</span></div><div class="small guid">GUID: 3E7FEF5A-BB77-4985-8FC5-530E930970D4</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 3</div><div><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM3_ESM.docx" data-ga-action="click_feat_suppl">12967_2024_5263_MOESM3_ESM.docx</a><span style="color:gray"> (1.1M)</span></div><div class="small guid">GUID: 93E33E7A-F6F1-48CE-A998-1F9A84799E8C</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 4</div><div><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">12967_2024_5263_MOESM4_ESM.pdf</a><span style="color:gray"> (27M)</span></div><div class="small guid">GUID: A9967012-3F0E-4282-9514-D446D1F911FC</div></div></dd></dl><dl data-length="419" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The raw sequence data have been deposited in the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA006037) that are publicly accessible in Gene Expression Omnibus (GEO). Any additional information required to reanalyze the data reported in this paper is available from the corresponding author.</p></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="sec-a.o.b.m.a" class="sec sec-first"><h3 id="sec-a.o.b.m.atitle">Background</h3><p id="Par1" class="p p-first-last">The pathogenesis of thyroid-associated orbitopathy (TAO) remains incompletely understand. The interaction between immunocytes and orbital fibroblasts (OFs) play a critical role in orbital inflammatory and fibrosis. Accumulating reports indicate that a significant portion of plasma exosomes (Pla-Exos) are derived from immune cells; however, their impact upon OFs function is unclear.</p></div><div id="sec-a.o.b.m.b" class="sec"><h3 id="sec-a.o.b.m.btitle">Methods</h3><p id="Par2" class="p p-first-last">OFs were primary cultured from inactive TAO patients. Exosomes isolated from plasma samples of patients with active TAO and healthy controls (HCs) were utilized for functional and RNA cargo analysis. Functional analysis in thymocyte differentiation antigen-1<sup>+</sup> (Thy-1<sup>+</sup>) OFs measured expression of inflammatory and fibrotic markers (mRNAs and proteins) and cell activity in response to Pla-Exos. RNA cargo analysis was performed by RNA sequencing and RT-qPCR. Thy-1<sup>+</sup> OFs were transfected with miR-144-3p mimics/inhibitors to evaluate its regulation of inflammation, fibrosis, and proliferation.</p></div><div id="sec-a.o.b.m.c" class="sec"><h3 id="sec-a.o.b.m.ctitle">Results</h3><p id="Par3" class="p p-first-last">Pla-Exos derived from active TAO patients (Pla-Exos<sup>TAO&#x02212;A</sup>) induced stronger production of inflammatory cytokines and hyaluronic acid (HA) in Thy-1<sup>+</sup> OFs while inhibiting their proliferation. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and single sample gene set enrichment analysis (ssGSEA) suggested that the difference in mRNA expression levels between Pla-Exos<sup>TAO&#x02212;A</sup> and Pla-Exos<sup>HC</sup> was closely related to immune cells. Differential expression analysis revealed that 62 upregulated and 45 downregulated miRNAs in Pla-Exos<sup>TAO&#x02212;A</sup>, with the elevation of miR-144-3p in both Pla-Exos and PBMCs in active TAO group. KEGG analysis revealed that the target genes of differentially expressed miRNA and miR-144-3p enriched in immune-related signaling pathways. Overexpression of the miR-144-3p mimic significantly upregulated the secretion of inflammatory cytokines and HA in Thy-1<sup>+</sup> OFs while inhibiting their proliferation.</p></div><div id="sec-a.o.b.m.d" class="sec"><h3 id="sec-a.o.b.m.dtitle">Conclusion</h3><p id="Par4" class="p p-first-last">Pla-Exos derived from patients with active TAO were immune-active, which may be a long-term stimulus casual for inflammatory and fibrotic progression of TAO. Our finding suggests that Pla-Exos could be used as biomarkers or treatment targets in TAO patients.</p></div><div id="sec-a.o.b.m.e" class="sec sec-last"><h3 id="sec-a.o.b.m.etitle">Supplementary Information</h3><p class="p p-first-last">The online version contains supplementary material available at 10.1186/s12967-024-05263-y.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Thyroid-associated orbitopathy, Exosome, miRNA, Immune response, Fibrosis</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="Par5" class="p p-first">Thyroid associated orbitopathy (TAO), also known as Graves&#x02019; orbitopathy (GO), is a complex and intractable autoimmune disorder [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>]. It has a high prevalence in various countries and regions of the world, with an overall incidence of 0.5%, predominantly affecting women, typically in their third to fifth decade [<a href="#CR2" rid="CR2" class=" bibr popnode">2</a>]. Previous studies demonstrated that the pathophysiology of TAO involves the crosstalk of insulin-like growth factor 1 receptor with thyrotropin receptor, causing progressive orbital tissue inflammation and remodeling, ultimately resulting in substantial disfigurement and visual impairment [<a href="#CR3" rid="CR3" class=" bibr popnode">3</a>, <a href="#CR4" rid="CR4" class=" bibr popnode">4</a>]. Although most cases of TAO are mild or self-limiting, up to &#x0223c;30% require treatments that are usually of an anti-inflammatory/immunosuppressive nature [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>, <a href="#CR5" rid="CR5" class=" bibr popnode">5</a>]. However, these therapeutic effects remain poor or inconclusive. Hence developing an interventive measure based on the pathogenesis level of TAO is the goal of treatment, which is complicated and challenging.</p><p id="Par6">Recent studies have provided extraordinary insight into the pathogenesis of TAO yet remains poorly understood, making it hard to treat effectively. Various inflammatory cells implicated in TAO activity, including T cells [<a href="#CR6" rid="CR6" class=" bibr popnode">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode">7</a>], B cells [<a href="#CR6" rid="CR6" class=" bibr popnode">6</a>], monocytes/macrophages [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>] and mast cells [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>], play an important role in maintaining orbital inflammatory environment, releasing numerous cytokines (CKs), growth factors (GFs) and other inflammatory mediators, many of which act as potent stimulators of hyaluronic acid (HA) accumulation and adipogenesis [<a href="#CR4" rid="CR4" class=" bibr popnode">4</a>, <a href="#CR7" rid="CR7" class=" bibr popnode">7</a>, <a href="#CR8" rid="CR8" class=" bibr popnode">8</a>]. As orbital tissue resident cells, orbital fibroblasts (OFs) are activated to secret a variety of inflammatory mediators, thereby continuing to recruit immune cells into the orbit [<a href="#CR7" rid="CR7" class=" bibr popnode">7</a>, <a href="#CR9" rid="CR9" class=" bibr popnode">9</a>]. This interaction between immunocytes and OFs maintains and exacerbates intraorbital inflammation. Inhibition of these complex immune-inflammatory processes is crucial for treatment of TAO, potentially sparing patients from undergoing multiple invasive surgeries. While chemokines and cytokines are known modulators of the immune response, exosomes have recently been identified as having a pivotal communicatory role in the initiation and resolution of inflammation [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>].</p><p id="Par7">Exosomes (exos), with a size range of &#x0223c;40 to 160&#x000a0;nm (average&#x02009;&#x0223c;100&#x000a0;nm), are a subset of extracellular vehicles (EVs) for cell-to-cell communication [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode">12</a>]. They carry various types of cargo, including RNA molecules, proteins and lipids that reflect the cell of origin [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode">12</a>]. Hence, the relative abundance ofdifferent exosomal molecules may reflect &#x02013; potentially pathologic &#x02013; changes in the relative cellular mechanisms affecting their release. Additionally, it is possible that one species of exosomal biomolecules may exhibit altered functional properties independently from another. It&#x02019;s important to note that immune-related cells activation impacts exosomal composition and function, and cells exposed to such exosomes contribute to inflammation/autoimmunity, cell injury, and cellular dysfunction [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR13" rid="CR13" class=" bibr popnode">13</a>]. Also, immunocyte-derived exosomes constitute a large component of peripheral blood exosomes [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>]. Numerous studies have indicated that plasma exosomes (Pla-Exos) affect both proinflammatory and profibrotic processes in inflammatory/autoimmune diseases and can also alter proliferation and apoptosis in cells [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>&#x02013;<a href="#CR17" rid="CR17" class=" bibr popnode">17</a>]. Lee et al. [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>] found that exosomes in blood from patients with systemic lupus erythematosus (SLE) have the ability to stimulate peripheral blood mononuclear cells (PBMCs) to produce inflammatory cytokines. Similarly, plasma EVs induced liver cells to release inflammatory factors, leading to long-term liver fibrosis progression in patients with hepatitis C virus (HCV) [<a href="#CR16" rid="CR16" class=" bibr popnode">16</a>]. Exosome miRNA-26b-3p in plasma from individuals with idiopathic short stature inhibited chondrocyte proliferation and impairs longitudinal bone growth [<a href="#CR17" rid="CR17" class=" bibr popnode">17</a>]. In addition, Hiratsuka et al. [<a href="#CR18" rid="CR18" class=" bibr popnode">18</a>] found that the differentially expressed circulating exosomal miRNAs were related to disease activity and involved in the regulation of immunocyte activation, playing an important role in the pathogenesis of Graves&#x02019; disease. This combined evidence suggests the need to investigate the impact of Pla-Exos on TAO development.</p><p id="Par8" class="p p-last">In this study, we assessed the influence of Pla-Exos on orbital inflammatory and fibrosis progression by analyzing the function and content of Pla-Exos. We first investigated the function of Pla-Exos derived from patients with active TAO (Pla-Exos<sup>TAO&#x02212;A</sup>) or healthy controls (HCs)(Pla-Exos<sup>HC</sup>)on human OFs. Secondly, we analyzed the RNA cargo of exosomes and highlighted the essential roles of miRNA, particularly those derived from PBMCs, in exosome-mediated dysfunction of OFs. Here, we provide the first evidence that Pla-Exos<sup>TAO&#x02212;A</sup> are immune- and fibrotic-active for their structural modifications. Accordingly, the inflammatory process of TAO might produce &#x0201c;TAO-specific&#x0201d; exosomes that might, in return, amplify the abnormal immune response and fibrosis.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods and materials</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Human samples</h3><p id="Par9" class="p p-first">Blood samples were obtained from patients with active TAO (TAO-A) (<em>n</em>&#x02009;=&#x02009;25) and healthy controls (HCs) (<em>n</em>&#x02009;=&#x02009;25). Venous blood (4&#x000a0;ml) was collected in Vacutainer Plus blood collection tubes containing EDTA (BD Biosciences, San Jose, CA, USA). Plasma was obtained from blood samples via centrifugation (300 &#x000d7; g, 10&#x000a0;min, 4&#x000a0;&#x000b0;C; 3000&#x000d7; g, 15&#x000a0;min, 4&#x000a0;&#x000b0;C) to remove cell debris and large apoptotic bodies before storage at &#x02212;&#x02009;80&#x000a0;&#x000b0;C. Peripheral blood mononuclear cells (PBMCs) were isolated from fresh whole blood and stored at &#x02212;&#x02009;80&#x000a0;&#x000b0;C. Orbital connective tissues (OCTs) were obtained from inactive TAO patients (TAO-NA ) (<em>n</em>&#x02009;=&#x02009;5) who underwent orbital decompression surgery, using automated dissociators and a 0.9% saline solution for the dissociation process, followed by preservation in phosphate-buffered saline (PBS) (Biological Industries, Kibbutz Beit Haemek, Israel) until cell extraction.</p><p id="Par10" class="p p-last">The enrolled patients in this study met the following inclusion criteria: (1) Diagnosis of TAO based on the Bartly criteria [<a href="#CR19" rid="CR19" class=" bibr popnode">19</a>]; (2) aged between 18 and 70 years. The following exclusion criteria were applied: (1) A previous history of inflammatory/ autoimmune, metabolic, or neoplastic diseases; (2) treatment with glucocorticoids and/or immunosuppressive agents within the past 3 months; or (3) pregnancy or lactation in women. In all patients, 7-item Clinical activity score (CAS) [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>] was used to assess TAO activity, with CAS&#x02009;&#x02265;&#x02009;3 indicating active TAO. This study received the approval of the Ethics Committee of the Eye Hospital of Wenzhou Medical University, Wenzhou, China (2022-109-K-83). Written informed consent from all patients and HCs. The authors confirm that all experiments were performed in accordance with the relevant guidelines and regulations.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Exosome isolation</h3><p id="Par11" class="p p-first-last">Exosomes were isolated from plasma samples of active TAO patients and HCs by size exclusion chromatography (SEC) using Exosupur&#x000ae; columns (35&#x000a0;nm, Echobiotech, Beijing, China). Briefly, the plasma samples were rapidly thawed at 37&#x02103;, centrifuged at 10,000&#x000d7;g for 30&#x000a0;min at 4&#x000a0;&#x000b0;C, and processed through a 0.22&#x000a0;&#x003bc;m filter to remove large particles. Subsequently, the samples underwentfurther purification using Exosupur&#x000ae; columns according to the manufacturer&#x02019;s instructions. The elution of the samples was carried out with PBS and a total of 2 mL eluate fractions were collected. These fractions were concentrated to 200 &#x000b5;L by 100&#x000a0;kDa molecular weight cut-off Amicon&#x000ae; Ultra spin filters (Merck, Germany). Exosomes were quantified using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL, USA), and the usage quantity of exosome were calculated. Equal exosomes (50&#x000a0;&#x000b5;g/mL) were added into thymocyte differentiation antigen-1<sup>+</sup> (Thy-1<sup>+</sup>) OFs.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Western blot</h3><p id="Par12" class="p p-first-last">Proteins from exosomes or PBMCs were prepared as described previously [<a href="#CR21" rid="CR21" class=" bibr popnode">21</a>]. Subsequently, the protein lysates were electrophresed on 10% SDS-PAGE gels. Following electrophoresis, proteins were transferred onto polyvinylidene fluoride (PVDF) membranes and blocked at room temperature in Tris-buffered saline/0.3% Tween20 containing 4% of bovine serum albumin (BSA). The membranes were then incubated overnight at 4&#x000a0;C with CD63 (ab68418, 1&#x000a0;&#x000b5;g/mL, Abcam, Cambridge, MA, USA), Alix (12422-1-AP, 1/1000 dilution, Proteintech, Chicago, USA), TSG101 (ab125011, 1/1000 dilution, Abcam) or Calnexin antibodies (10427-2-AP, 1/1000 dilution, Proteintech) diluted 1/1000 in 1% BSA. After washing 3 times with TBST, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody ( A0208, 1/1000 dilution, Beyotime, Shanghai, China) at room temperature for 2&#x000a0;h. Finally, signals were detected using a chemiluminescence kit (34,580, Thermo Fisher Scientific). The chemiluminescence reaction was visualized in iBright FL500 imaging system (Thermo Fisher Scientific).</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Nanoparticle tracking analysis (NTA)</h3><p id="Par13" class="p p-first-last">The Vesicle suspensions with concentrations between 1&#x02009;&#x000d7;&#x02009;10<sup>7</sup> /ml and 1&#x02009;&#x000d7;&#x02009;10<sup>9</sup> /ml were examined using the ZetaView PMX 110 (Particle Metrix, Meerbusch, Germany) equipped with a 405&#x000a0;nm laser to determine the size and quantity of the particles we isolated. A video of 60-sec duration was taken with a frame rate of 30 frames/sec, and particle movement was analyzed using NTA software (ZetaView 8.02.28).</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Transmission electron microscopy (TEM)</h3><p id="Par14" class="p p-first-last">Ten &#x000b5;L purified fresh exosomes were placed on a carbon-coated copper grid and incubated at room temperature for 1&#x000a0;min. Then the exosome was immersed in 2% uranyl acetate solution for 1&#x000a0;min. Excess fluid was removed using filter paper. The exosomes were observed and imaged under a transmission electron microscope (H-7650, Hitachi Ltd., Tokyo, Japan) at an accelerating voltage of 80&#x000a0;kV.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">PBMCs isolation</h3><p id="Par15" class="p p-first-last">PBMCs were isolated from fresh whole blood using Ficoll-Paque density-gradient centrifugation. First, the samples were diluted at least 2-fold with PBS. Then, 3 mL of Ficoll-Paque&#x02122; PREMIUM separation solution (Cytiva, Uppsala, Sweden) was added to SEPMATE-15 (STEMCELL&#x02122; Technologies, Vancouver, Canada), followed by the addition of 5 mL of diluted blood without disrupting the upper surface of the Ficoll separation solution. Samples were centrifuged at 400 <em>g</em> for 30&#x000a0;min at room temperature (18&#x02013;22&#x02103;). Buffy coat&#x02013;containing PBMCs were transferred to a new 15-mL centrifuge tube using a 1-mL manual pipette and washed twice with PBS. Red blood cell lysis buffer (Beyotime) was added and placed on ice for 4&#x000a0;min before PBS was added again. The samples were centrifuged and PBMCs were eventually dissolved in freezing medium (90/10 PBS/dimethyl sulfoxide). PBMCs were stored in liquid nitrogen until needed.</p></div><div id="Sec9" class="sec"><h3 id="Sec9title">Cell preparation</h3><p id="Par16" class="p p-first">Primary orbital fibroblasts were extracted from OCTs of TAO-NA patients. After removing adipose tissues and blood vessels, the OCTs were cut into 1- to 2-mm pieces, and then planted in Petri dishes. Dulbecco&#x02019;s Modified Eagle Medium/Nutrient Mixture F12 (DMEM/F-12) (Biological Industries) supplemented with 20% fetal bovine serum (FBS) (HyClone, GE Healthcare, Logan, USA), 1% GlutaMAX (Gibco, New York, USA), 100&#x000a0;mg/mL streptomycin and 100 IU/mL penicillin (Gibco) was slowly added to cover the small tissue pieces. The orbital tissue pieces were grown in a cell incubator at 37&#x02103; and 5% CO<sub>2</sub>. The medium was changed every 3 days, and OFs were obtained with 0.05% Trypsin-EDTA (Gibco) after the cells grew to confluence. The cultured strains were used between the third and sixth passages.</p><p id="Par17" class="p p-last">Thy-1<sup>+</sup> OFs prepared using CD90 MicroBeads (human), LS Columns and manual MACS magnetic separator (all from Miltenyi Biotec, Bergisch Gladbach, North Rhine-Westphalia, Germany) according to the manufacturer&#x02019;s instructions. Separation of pure Thy-1<sup>+</sup> OFs was accomplished by 2 rounds of magnetic selection. The Thy-1<sup>+</sup> subset was determined by flow cytometry. The cells were washed and resuspended in stain buffer (BD Biosciences, San Jose, CA, USA), and then incubated with allophycocyanin (APC)-conjugated mouse anti-human Thy-1 (CD90) antibody or APC-conjugated mouse IgG1 &#x003ba; isotype control antibody (both from BD Biosciences, San Jose, CA, USA) for 20&#x000a0;min at 4&#x000a0;&#x000b0;C. After 2 washes, the cells were resuspended in 200 &#x000b5;L staining buffer and subjected to flow cytometric analysis (BD Canto II, Franklin Lakes, NJ, USA).</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">Immunofluorescence</h3><p id="Par18" class="p p-first-last">Thy-1<sup>+</sup> OFs were seeded in 24-well plates on coverslips at approximately 2&#x02009;&#x000d7;&#x02009;10<sup>4</sup> per well and cultured overnight at 37 &#x02103; in an atmosphere of 5% CO<sub>2</sub>. After washing three times with PBS, the cells were fixed with 4% paraformaldehyde for 20&#x000a0;min, permeabilized with PBS containing 0.2% Triton X-100 (PBST) for 30&#x000a0;min and blocked with 3% BSA/PBS for 30&#x000a0;min at room temperature. The cells were then incubated overnight with primary antibodies against fibroblast surface protein (FSP) (SAB4200821, 5&#x000a0;&#x000b5;g/mL, Sigma-Aldrich, Saint Louis, MO, USA) and vimentin (VIM) (ab137321, 1/500 dilution, Abcam) at 4&#x000b0;C. Then the slides were washed with PBS for 5&#x000a0;min again and incubated with Alexa Fluor 488 goat anti-mouse IgG or Alexa Fluor 594 goat anti-Rabbit IgG secondary antibody (Bioss, Beijing, China) at room temperature in the dark for 1&#x000a0;h. All the agents were applied in accordance with the manufacturer&#x02019;s instructions. Nuclei were stained for 10&#x000a0;min with DAPI (Beyotime). After a final wash, an anti-fluorescence quenching agent (Beyotime) was added to mount the coverslips. Images were obtained using Leica DM4B (Leica Microsystems, Br&#x000f8;nsh&#x000f8;j, Denmark).</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Exosome labeling and tracking</h3><p id="Par19" class="p p-first-last">Purified exosomes isolated from plasma samples of active TAO patients were labeled with PKH67 (Sigma-Aldrich) following the manufacturer&#x02019;s instructions. We incubated exosomes with 500 &#x000b5;L Dilution C solution and 2&#x000a0;&#x000b5;l PKH67 dye in 500 &#x000b5;L Dilution C solution for 3&#x000a0;min in a dark environment. To stop the staining process, 1 mL 1% BSA/PBS was added to bind any excess dye. The exosomes were then re-extracted to remove free PKH67 dye by ultracentrifugation (100,000&#x000d7;g, 70&#x000a0;min, 4 &#x02103;) and subsequently added to unstained Thy-1<sup>+</sup> OFs (10<sup>4</sup> cells per well in 24-well plates) to evaluate exosome uptake. Following incubation for 12&#x000a0;h at 37&#x000a0;&#x000b0;C, the cells were fixed and stained with DAPI for 10&#x000a0;min at room temperature. Cells were observed and imaged using a confocal microscope (Leica DM4b, Wetzlar, Germany).</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Cell culture and treatment</h3><p id="Par20" class="p p-first-last">To ensure consistent initial conditions for all experiments, we added 20% FBS to the medium when we started cultures from tissues or from frozen cell stocks. In addition, we used 10% FBS when pretreating the cells to ensure normal growth. To synchronize the cells in the same cell cycle phase, we replaced the culture medium with a medium containing 1% FBS before the stimulation with exosomes. Thy-1<sup>+</sup> OFs were incubated with exosomes (50&#x000a0;&#x000b5;g/mL) isolated from plasma samples of HCs and active TAO patients in a medium containing 10% exosome-depleted FBS (System Biosciences, Exo-FBS-50&#x000a0;A-1, USA) at 37&#x02103; in a humidified 5% CO<sub>2</sub> atmosphere for 3 days (mRNA detection) and 4 days (protein detection). miR-144-3p mimics (100 nM) or inhibitors (200 nM) were transfected into Thy-1<sup>+</sup> OFs using attractene transfection reagent (QIAGEN, Frederick, MD, Germany) per manufacturer&#x02019;s protocol. Two days after transfection, the cells were harvested with TRIzol for RNA analysis. Three days after transfection, the supernatant was collected in tubes for protein analysis. MiR-144-3p mimics/inhibitors, control mimics/inhibitors were purchased from Guangzhou RiboBio Co., Ltd. (China), and their sequences are listed in Table <a href="#MOESM1" rid="MOESM1" class=" media">S1</a>.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">RNA isolation and RT-qPCR</h3><p id="Par21" class="p p-first-last">Total RNA was extracted from cells using TRIzol reagent (Beyotime) and from exosomes (derived from 500 &#x000b5;L plasma) using RNeasy Mini Kit (QIAGEN) according to the manufacturer&#x02019;s instructions. RNA concentration and purity were quantified using a Multiskan Mk3 System (Thermo Fisher Scientific). Reverse transcription of 300 ng RNA into cDNA was performed using the HiScript&#x000ae;III RT SuprtMix for qPCR with gDNA wiper (Vazyme, Nanjing, China), followed by amplification using the Applied Biosystems Veriti PCR system (Thermo Fisher Scientific). RT-qPCR was performed with Taq Pro Universal SYBR qPCR Master Mix (Vazyme) using QuantStudio&#x02122; 3 Real-Time PCR System (Thermo Fisher Scientific). Delta delta CT method was used to calculate genes/miRNAs expression. Gene expression results was normalized to the expression level of GAPDH; exosomal miRNA expression results were normalized to the expression level of miR-33a-5p; cell miRNA expression results were normalized to the expression level of U6. All primers are synthesized by Guangzhou RiboBio Co., Ltd., and RT primers and qPCR primers are listed in Table <a href="#MOESM2" rid="MOESM2" class=" media">S2</a> and Table <a href="#MOESM3" rid="MOESM3" class=" media">S3</a>.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">High-throughput sequencing of exosomal RNA</h3><p id="Par22" class="p p-first-last">Total RNA in exosomes extracted from plasma samples in the HC and TAO-A groups (<em>n</em>&#x02009;=&#x02009;5 for each group) was sent to EchoBiotech Co. Ltd (Beijing, China) for whole transcriptome sequencing. The QIAseq miRNA Library Kit (QIAGEN) and SMARTer Stranded Total RNA-Seq Kit v2 (TAKARA, San Jose, CA, USA) were used to create miRNA and lncRNA libraries respectively, and the quality of the libraries was assessed on the Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA) and qPCR. Finally, the quantified libraries were sequenced using an Illumina NovaSeq 6000 platform (San Diego, CA, USA).</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Bioinformatics analysis</h3><p id="Par23" class="p p-first-last">Quality control was performed on raw reads using Fastp (version 1.0), and clean reads were obtained by aligning with Silva database, GtRNAdb database, Rfam database and Repbase database to filter the low-quality data. Then, HISAT2 (version 2.2.0), Stringtie (version 1.3.6), and miRDeep2 (version 0.1.3) software were respectively used to map and annotate mRNAs, lncRNAs, and miRNAs based on the Human Genome (version GRCm38) and miRBase. Afterward, the RNA expression levels from the 10 samples were first transformed on a log<sub>2</sub> scale before principal component analysis (PCA). PCA was performed using the prcomp function in stats package in R3.6.1. Using edgeR package (version 3.40.0) in R3.6.1, differentially expressed lncRNAs (DE-lncRNAs), miRNAs (DE-miRNAs) and mRNAs (DE-mRNAs) were screened at the thresholds of fold change&#x02009;&#x0003e;&#x02009;1.5 and <em>p</em>&#x02009;&#x0003c;&#x02009;0.05. Hierarchical clustering analysis was applied to depict the expression pattern of different transcripts using Pheatmap package (version 1.0.8) in R3.6.1. To visualize volcano plots, we utilized the plot function in the graphics package in R. We performed in silico analysis to identify putative miRNA target genes using TargetScan, miRanda, PicTar, MicroCosm Targets and miRDB; the genes predicted in at least three sites were identified as the target genes of DE-mRNAs. Subsequently, functional and pathway enrichment analyses were performed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, and the enrichment score generated by -log10 (p-value) / <em>P</em>&#x02009;&#x0003c;&#x02009;0.05 depicted the importance of the pathway correlations. Single-sample gene-set enrichment analysis (ssGSEA) on DE-mRNAs was carried out by GSVA package (version 1.48.3) in R3.6.1, and the normalized ssGSEA score was calculated to evaluate the enrichment levels of immunocytes in each sample [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. In addition, miRcode was used to predict miRNA binding sites to predict the interactions between miRNA and its target genes, and the nodes are linked with enriched genes. Table <a href="#MOESM4" rid="MOESM4" class=" media">S4</a> gives an overview about several databases available.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Enzyme-linked immunosorbent assay (ELISA)</h3><p id="Par24" class="p p-first-last">The concentrations of IL-1&#x003b2;, IL-6, TNF-&#x003b1;, CXCL2, and RANTES and HA in the cell culture supernatant were quantified with ELISA kits (R&#x00026;D Systems, Minneapolis, MN, USA) according to the manufacturer&#x02019;s instructions.</p></div><div id="Sec17" class="sec"><h3 id="Sec17title">Cell counting kit-8 (CCK-8) assay</h3><p id="Par25" class="p p-first-last">Cell proliferation was evaluated by CCK-8 assay. Thy-1<sup>+</sup> OFs were inoculated into 96-well cell culture plates at 3000 cells per well in complete medium, then treated with exosome or miR-144-3p mimics/inhibitors. Ten &#x000b5;l CCK-8 solution (Beyotime) was added to each well, and cells were incubated again for 1.5&#x000a0;h. The absorbance at 450&#x000a0;nm was measured using a microplate reader (Thermo Multiskan MK3, USA) at 0&#x000a0;h, 24&#x000a0;h, 48&#x000a0;h, 72&#x000a0;h, or 96&#x000a0;h.</p></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">Statistical analysis</h3><p id="Par26" class="p p-first-last">Statistical analyses were performed using GraphPad Prism (vision 9.3.5). Student&#x02019;s <em>t</em>-test was used to compare two groups, and one-way ANOVA for multiple group comparison. All the data were presented as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD). Differences were considered significant when <em>p</em>&#x02009;&#x0003c;&#x02009;0.05.</p></div></div><div id="Sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec19title">Results</h2><div id="Sec20" class="sec sec-first"><h3 id="Sec20title">Study design and patient characteristics</h3><p id="Par27" class="p p-first">As demonstrated by the overall workflow (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>a), the study consisted of two parts: a functional study and a mechanistic study. Functional analysis of exosomes was performed on Thy-1<sup>+</sup> OFs (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>b). Exosomes were obtained from plasma samples of patients with active TAO (<em>n</em>&#x02009;=&#x02009;5) and HCs (<em>n</em>&#x02009;=&#x02009;5), and the OFs were separated from orbital connective tissues (OCTs) of patients with inactive TAO (TAO-NA) (<em>n</em>&#x02009;=&#x02009;5) who underwent orbital decompression surgery. Mechanistic analysis was performed using RNA content (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>c). First, we performed a discovery study for RNA expression profile using whole transcriptome high-throughput sequencing analysis and analyzed the differentially expressed RNAs in exosomes from the same plasma samples as described above. Next, another series of plasma samples were collected from patients with active TAO (<em>n</em>&#x02009;=&#x02009;20) and HCs (<em>n</em>&#x02009;=&#x02009;20) to validate the exosome miRNA expression profile. The miR-144-3p level was evaluated in both Pla-Exos and PBMCs, and the network and functional analysis were made to show its potential function. Finally, miR-144-3p was screened as a potential functional biomolecule for functional analysis. The clinical characteristics of the patient populations studied are shown in Table <a href="#MOESM3" rid="MOESM3" class=" media">S5</a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC11157872/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697856324240"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figa_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figa_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figa_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697856324240"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p>Design of the study. <strong>(a)</strong> An overall workflow of the entire study. <strong>(b)</strong> The protocol used in the functional study. After adding exosomes 3 days (mRNA detection) or 4 days (protein detection), the inflammatory markers, fibrosis markers, and cell proliferation in Thy-1<sup>+</sup> OFs were assessed. <strong>(c)</strong> The protocol used in the mechanistic study of exosomes. Exosomal RNA content was analyzed using RNA-seq and RT-qPCR. Immune cell-derived miRNA was selected using RT-qPCR. miR-144-3p was selected as an immunocyte-derived miRNA and miR-144-3p mimics/inhibitors were transfected into Thy-1<sup>+</sup> OFs to evaluate its regulation of inflammation, fibrosis, and cell proliferation. TAO-A active TAO patients, HCs healthy controls, TAO-NA inactive TAO patients, OCT orbital connective tissue, PBMCs peripheral blood mono-nuclear cells, OFs orbital fibroblasts, RNA-seq RNA sequencing, HA hyaluronic acid</p></div></div></div><p id="Par46" class="p p-last">

</p></div><div id="Sec21" class="sec"><h3 id="Sec21title">Plasma exosomes were taken up into OFs</h3><p id="Par28" class="p p-first">Exosomes were purified from plasma samples of patients with active TAO and HCs using SEC and identified using western blotting, NTA and TEM (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>a &#x02013; c). Western blotting results suggested that the vesicles positively expressed the exosome protein markers CD63, Alix, and TSG101, and were negative for the Golgi marker &#x02013; Calnexin (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>a). TEM showed that the exosomes were cup-shaped or round, with a diameter of approximately 100&#x000a0;nm (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>b). Additionally, NTA revealed most exosomes to be predominantly in the 50&#x02013;150&#x000a0;nm size range (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>c). No significant differences in exosome concentrations existed between the two groups (Fig. <a href="#MOESM1" rid="MOESM1" class=" media">S1</a>). Hence, the vesicles we isolated were confirmed to be exosomes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697849377856"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figb_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figb_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figb_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697849377856"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><p>Plasma exosomes were taken up by human OFs. <strong>(a-c)</strong> Characterization of Pla-Exos. <strong>(a)</strong> Western blot analysis identified positive expression of exosomes markers CD63, Alix and TSG101, with the negative expression of Golgi marker Calnexin in the extraction samples. <strong>(b)</strong> Nano-Sight analysis indicated that the size of the extraction was approximately 100&#x000a0;nm. <strong>(c)</strong> The morphology of the extraction was examined via transmission electron microscope. <strong>(d, e)</strong> Characterization of OFs. <strong>(d)</strong> Immunofluorescence staining of OFs reveals the uniform expression of the fibroblast markers FSP and vimentin. Cells were stained with anti-FSP and anti-vimentin antibodies and Alexa Fluor 488/594-conjugated secondary antibodies (fluorescence microscopy, 20; scale bars, 50&#x000a0;&#x003bc;m). <strong>(e)</strong> OFs were analyzed for Thy-1 expression using flow cytometry (right). The Thy-1<sup>+</sup> subset was obtained from parental OFs after 2 rounds of magnetic bead sorting. Thy-1<sup>+</sup> OFs were &#x0003e;&#x02009;99% positive for Thy-1 (left). <strong>(f)</strong> Pla-Exos (green) were transferred into OFs (blue) (fluorescence microscopy, 20). FSP fibroblast surface protein, VIM vimentin</p></div></div></div><p id="Par47">

</p><p id="Par29">Thy-1<sup>+</sup> OFs were separated from the OCTs of patients with inactive TAO and examined by immunofluorescence assays and flow cytometry (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>d, e). The oblong, spindle-shaped cells were morphologically consistent with the fibroblast phenotype, and they grew in adherent monolayers to plastic substratum. These fibroblasts maintained a stable phenotype over the indicated culture interval and uniformly expressed fibroblast surface protein 1 (FSP-1) and vimentin (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>d). Thy-1 (CD90) expression in OFs was evaluated by flow cytometry. The Thy-1<sup>+</sup> subset was isolated from parental OFs via 2 rounds of magnetic bead selection. Thy-1<sup>+</sup> fibroblasts were &#x0003e;&#x02009;99% positive for Thy-1 (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>e). All these indicated that the cultured cells were Thy-1<sup>+</sup> OFs.</p><p id="Par30" class="p p-last">To confirm that exosomes could be transferred into Thy-1<sup>+</sup> OFs, we labeled Pla-Exos with a fluorescent membrane marker PKH67. The PKH67-labeled Pla-Exos were incubated with unstained Thy-1&#x02009;<sup>+</sup>&#x02009;OFs for 12&#x000a0;h. Confocal imaging revealed the delivery of labeled exosomes, as indicated by the presence of fluorescent membrane dyes in unlabeled OFs (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>f).</p></div><div id="Sec22" class="sec"><h3 id="Sec22title">Plasma exosomes derived from patients with active TAO promotes Thy-1<sup>+</sup> OFs inflammation and fibrosis</h3><p id="Par31" class="p p-first">To investigate whether Pla-Exos acts as an agonist or antagonist in TAO development, Thy-1<sup>+</sup> OFs were pretreated with Pla-Exos derived from patients with active TAO or HCs (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>a). As shown in Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>b and c, Pla-Exos<sup>TAO&#x02212;A</sup> induced higher levels of inflammatory molecules (IL-1&#x003b2;, IL-6, TNF-&#x003b1;, CXCL2 and RANTES) than Pla-Exos<sup>HC</sup>-treated and untreated Thy-1<sup>+</sup> OFs. Notably, the mRNA level of the fibrogenic marker hyaluronan synthase (HAS) 1 was significantly higher in Thy-1<sup>+</sup> OFs treated with Pla-Exos<sup>TAO&#x02212;A</sup> (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>d), and this observation was confirmed at the protein level for HA (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>e); however, Pla-Exos<sup>HC</sup> didn&#x02019;t share this ability. Excessive HA production is one of the main components responsible for orbital tissue expansion and fibrosis in TAO. Besides, neither TAO-A- nor HC-derived Pla-Exos stimulated the secretion of &#x003b1;-smooth muscle actin (a-SMA) and Collagen in Thy-1<sup>+</sup> OFs (Fig. <a href="#MOESM2" rid="MOESM2" class=" media">S2</a>b). Finally, a dramatic reduction in the proliferation of Thy-1<sup>+</sup> OFs was observed under Pla-Exos<sup>TAO&#x02212;A</sup> stimulation (<em>P&#x02009;&#x0003c;</em>&#x02009;0.0001), while this feature wasn&#x02019;t observed in Thy-1<sup>+</sup> OFs treated with Pla-Exos<sup>HC</sup> (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>f, g). These data provide evidence for a plasma exosome-mediated inflammatory and fibrogenic stimulus in patients with active TAO. In contrast, plasma exosomes derived from patients with active TAO inhibited cell viability of Thy-1<sup>+</sup> OFs compared with those derived from HCs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697837653536"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figc_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figc_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figc_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697837653536"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><p>Plasma exosomes derived from patients with active TAO induced stronger production of cytokines and HA in Thy-1<sup>+</sup> OFs and inhibited their proliferation. <strong>(a)</strong> Diagram of the Pla-Exos treating Thy-1<sup>+</sup> OFs. Pla-Exos (50&#x000a0;&#x000b5;g/mL) derived from 5 HCs and 5 patients with active TAO were added to Thy-1<sup>+</sup> OFs. mRNA and protein detection were performed after 72&#x02013;96&#x000a0;h, respectively. <strong>(b, c)</strong> Pla-Exos<sup>TAO&#x02212;A</sup> induced stronger production of inflammatory molecules in Thy-1<sup>+</sup> OFs. The mRNA levels of IL-1&#x003b2;, IL-6, TNF-a, CXCL2 and RANTES determined by RT-PCR and normalized to GAPDH mRNA levels are shown in <strong>(b)</strong>. The concentrations of IL-1&#x003b2;, IL-6, TNF-a, CXCL2 and RANTES in cell supernatants detected by ELISA are shown in <strong>(c)</strong>. <strong>(d, e)</strong> Pla-Exos<sup>TAO&#x02212;A</sup> induced stronger production of HA in Thy-1<sup>+</sup> OFs. The mRNA levels of HAS1 are shown in (d). The concentrations of HA in cell supernatants are shown in <strong>(e)</strong>. <strong>(f, g)</strong> Pla-Exos<sup>TAO&#x02212;A</sup> inhibited the proliferation of Thy-1<sup>+</sup> OFs. Data are representative of 3 independent experiments. <em>n</em>&#x02009;=&#x02009;6 in each group. Error bars represent the mean&#x02009;&#x000b1;&#x02009;SD. ns, no significance, *<em>p</em>&#x02009;&#x0003c;&#x02009;0.05, **<em>p</em>&#x02009;&#x0003c;&#x02009;0.01, ***<em>p</em>&#x02009;&#x0003c;&#x02009;0.001, ****<em>P</em>&#x02009;&#x02264;&#x02009;0.0001, one-way ANOVA with Dunnett&#x02019;s comparison test. HA Hyaluronic acid, HAS hyaluronan synthase, SD standard deviation</p></div></div></div><p id="Par48" class="p p-last">

</p></div><div id="Sec23" class="sec"><h3 id="Sec23title">RNA signature of plasma exosomes derived from patients with active TAO</h3><p id="Par32" class="p p-first">To correlate functional properties with structural evidence, we further analyzed the RNA cargo in Pla-Exos isolated from the same patients with active TAO and HCs as described above. We investigated the RNA expression profiles of Pla-Exos by RNA sequencing (RNA-seq) and used a 1.5-fold change and <em>p</em> value&#x02009;&#x0003c;&#x02009;0.05 as the threshold to define differentially expressed RNAs.</p><p id="Par33">With respect to mRNA cargo, 243 upregulated mRNAs and 65 downregulated mRNAs were found in Pla-Exos<sup>TAO&#x02212;A</sup> compared with Pla-Exos<sup>HC</sup> (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>a, b). KEGG analysis revealed that the DE-mRNAs were enriched in the immune-related signaling pathways, such as TGF-&#x003b2; signaling pathway and leukocyte transendothelial migration (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>c). Among the DE-mRNAs, we identified 27 categories of immune-related maker genes (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>d, Table <a href="#MOESM4" rid="MOESM4" class=" media">S6</a>). Considering that exosomes react to the functional state of the source cell, we explored the relationship between exosome-mRNAs and immune-related cells. ssGSEA was carried out to evaluate the enrichment levels of immunocytes in each Pla-Exos sample. We estimated 29 immune-related cells including 13 innate immunocytes (activated dendritic cells (DCs), CD56<sup>bright</sup> natural killer (NK) cells, CD56<sup>dim</sup> NK cells, eosinophils, immature DCs, macrophages, mast cells, myeloid-derived suppressor cells, monocytes, NK cells, natural killer T cells, neutrophils, and plasmacytoid DCs), 15 adaptive immunocytes (activated B cells, activated CD4 T cells, activated CD8 T cells, central memory CD4 T cells, central memory CD8 T cells, effector memory CD4 T cells, effector memory CD8 T cells, &#x003b3;&#x003b4;T cells, immature B cells, memory B cells, regulatory T cells, T follicular helper cells, Th1 cells, Th17 cells, and Th2 cells), and endothelial cell, with their marker genes were obtained from previous studies [<a href="#CR23" rid="CR23" class=" bibr popnode">23</a>, <a href="#CR24" rid="CR24" class=" bibr popnode">24</a>], as shown in Table <a href="#MOESM1" rid="MOESM1" class=" media">S7</a>. Unsurprisingly, the results of ssGSEA revealed that the immune signatures of Th1 cells increased, and the immune signatures of NK cells and DCs decreased (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>e). Consistent with the functional analysis on Thy-1<sup>+</sup> OFs, Pla-Exos-mRNA correlated with a significant difference between HCs and active TAO patients, thus indicating that exosome-mediated signals still contained inflammatory informational content. These results also provide clues to the functional differences conferring to immune origin of exosomes.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697851561600"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figd_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figd_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figd_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697851561600"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><p>The exosomal mRNA profiles of patients with active TAO differed from those of healthy controls. <strong>(a)</strong> Heatmap of the mRNA expression profiles in the TAO-A and HC groups. Exosomes were isolated from the same plasma samples used in the functional analysis. RNA-seq was used for mRNA content analysis. <strong>(b)</strong> Volcano plot comparing mRNAs in Pla-Exos from patients with active TAO and HCs. The volcano plot was created using a log2 fold change and &#x02013;log10 <em>p</em> values of all the detected mRNAs. <strong>(c)</strong> Results of KEGG pathway analysis for the DE-mRNA. <strong>(d)</strong> The differentially expressed immune cells marker genes in exosomes were examined. <strong>(e)</strong> Enrichment levels of immune subpopulations in Pla-Exos. Th1 cell marker genes increased, while dendritic cell and natural killer cell marker genes decreased in Pla-Exos of active TAO patients. RNA-seq RNA sequencing, KEGG Kyoto Encyclopedia of Genes and Genomes analysis, DE-mRNA differential expressed mRNA.</p></div></div></div><p id="Par49">

</p><p id="Par34">With respect to miRNA cargo, no significant difference was found in the count of miRNA reads or the overall expression of these miRNAs in patients with active TAO and HCs (data not shown). However, when we analyzed the expression spectrum of individual miRNAs in Pla-Exos derived from patients with active TAO and HCs, we found that there were distinct profiles of expression (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>c), indicating the potential value of the exosome miRNA analysis for the diagnosis or treatment of active TAO. To further assess the differences between the groups, we performed a cluster analysis of differentially expressed miRNAs which highlighted 62 upregulated and 45 downregulated miRNAs in active TAO patients compared with HCs (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>a, b). As revealed by KEGG pathway analysis, the confirmed target genes of the DE-miRNAs were highly enriched in the immune-related signaling pathways (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>d). To confirm the DE-miRNAs, miRNA expression levels per equal volume of Pla-Exos were determined using RT-qPCR. We selected 15 DE-miRNAs that were coherently expressed at the same level in all ten samples for analysis (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>e; Table&#x000a0;<a href="/pmc/articles/PMC11157872/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>). The RT-qPCR analysis required the identification of stable miRNAs for use as reference factors. Consistent with previous research [<a href="#CR25" rid="CR25" class=" bibr popnode">25</a>], miR-33a-5p was found to have stable expression levels in both groups (Fig. <a href="#MOESM3" rid="MOESM3" class=" media">S3</a>a) and was therefore used as reference miRNA for normalization. Notably, expression levels of miR-134-5p, miR-144-3p, miR-431-5p, and miR-483-3p were increased in Pla-Exos<sup>TAO&#x02212;A</sup> compared to Pla-Exos<sup>HC</sup> (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>f). This analysis is conceivably causally associated with the functional observation previously described, since both bioinformatic predictions and previous reports pinpoint many of these DE-miRNAs as regulators of inflammatory and fibrotic markers.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697835892048"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Fige_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Fige_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Fige_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697835892048"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><p>The exosomal miRNA profiles of patients with active TAO differed from those of healthy controls. <strong>(a)</strong> Heatmap of the miRNA expression profiles in Pla-Exos in HC and TAO-A groups. Exosomes were isolated from the same plasma samples used in the functional analysis. RNA-seq was used for miRNA content analysis. <strong>(b)</strong> Volcano plot comparing miRNAs in Pla-Exos from patients with active TAO and HCs. The volcano plot was created using a log2 fold change and &#x02013;log10 <em>p</em> values of all the detected miRNAs. <strong>(c)</strong> PC analysis for the active TAO patients and HC samples based on the miRNA expression profiles. <strong>(d)</strong> KEGG pathway analysis of DE-miRNA target genes identified 20 immune-related pathways. <strong>(e)</strong> The differently expressed trends of candidate miRNAs in RNA-seq data. <strong>(f)</strong> Levels of miR-134-5p, miR-144-3p, miR-431-5p, and miR-483-3p in Pla-Exos determined by RT-PCR and normalized to the expression levels of miR-30a-5p. <em>n</em>&#x02009;=&#x02009;20 per group. PC principal component, KEGG Kyoto Encyclopedia of Genes and Genomes analysis, DE-miRNA differential expressed miRNA, A.U. arbitrary unit</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p>Differentially expressed miRNAs list in patients with active TAO vs. HC</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">Fold change</th><th align="left" rowspan="1" colspan="1"><em>p</em> value</th><th align="left" rowspan="1" colspan="1">FDR</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">hsa-miR-34&#x003b1;-5p</td><td align="left" rowspan="1" colspan="1">-4.2<sup>&#x02020;</sup></td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-218-5p</td><td align="left" rowspan="1" colspan="1">-3.9</td><td align="left" rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1">0.182</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-7&#x003b1;-3p</td><td align="left" rowspan="1" colspan="1">-3.4</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.185</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-483-3p</td><td align="left" rowspan="1" colspan="1">-2.9</td><td align="left" rowspan="1" colspan="1">0.004</td><td align="left" rowspan="1" colspan="1">0144</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-144-3p</td><td align="left" rowspan="1" colspan="1">-2.4</td><td align="left" rowspan="1" colspan="1">0.019</td><td align="left" rowspan="1" colspan="1">0.333</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-134-5p</td><td align="left" rowspan="1" colspan="1">3.8</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-432-5p</td><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-25-5p</td><td align="left" rowspan="1" colspan="1">2.4</td><td align="left" rowspan="1" colspan="1">0.023</td><td align="left" rowspan="1" colspan="1">0.360</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-382-5p</td><td align="left" rowspan="1" colspan="1">3.3</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-485-3p</td><td align="left" rowspan="1" colspan="1">3.8</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-6852-5p</td><td align="left" rowspan="1" colspan="1">3.2</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.176</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-504-5p</td><td align="left" rowspan="1" colspan="1">2.9</td><td align="left" rowspan="1" colspan="1">0.044</td><td align="left" rowspan="1" colspan="1">0.480</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-431-5p</td><td align="left" rowspan="1" colspan="1">3.7</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-370-3p</td><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">0.005</td><td align="left" rowspan="1" colspan="1">0.176</td></tr><tr><td align="left" rowspan="1" colspan="1">hsa-miR-625-3p</td><td align="left" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">0.000</td><td align="left" rowspan="1" colspan="1">0.062</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140697837839184"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p><sup>&#x02020;</sup> &#x0201c;-&#x0201d; indicates that exosomal miRNA expression is down-regulated in the TAO-A group compared with the HC group</p></div></div><p id="Par50">

</p><p id="Par35">

</p><p id="Par36">Only 23 lncRNAs were differentially expressed in Pla-Exos between HC and TAO-A groups, and almost all of them had low or unstable expression levels (Fig. <a href="#MOESM4" rid="MOESM4" class=" media">S4</a>). Therefore, further research was not conducted on them.</p><p id="Par37" class="p p-last">Overall, our data highlight a correlation between the function and the RNA contents of exosomes, implicating Pla-Exos as a relevant player in active TAO-related pathogenesis. Our data shows a few inflammatory modifications that act as a warning for the progression of long-term inflammatory response based on exosomes. We expected that monitoring the expression levels of these exosome-RNAs might prove to be useful for distinguishing active TAO and evaluating the clinical activity.</p></div><div id="Sec24" class="sec"><h3 id="Sec24title">MiR-144-3p expression is increased in PBMCs from patients with active TAO</h3><p id="Par38" class="p p-first">Activated circulating immune cells, particularly T cells, play a crucial role in the progression of TAO [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>]. Exosomes are known to contain similar contents and functions as their parent cells, attributed to the presence of a distinct signature of nucleic acids, proteins, and lipids that mirrors their cellular and tissue origin. A previous study has shown that exosomes derived from immune cells constitute a significant portion of Pla-exos [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>]. In this context, miRNA in Pla-Exos may serve as a tool for communication from activated leukocytes to OFs; therefore, the expression levels of miR-134-5p, miR-144-3p, miR-431-5p and miR-483-3p were further evaluated in PBMCs to identify functional miRNAs originating from immune cells. Compared with PBMCs derived from HCs, expression of miR-144-3p was elevated in PBMCs derived from patients with active TAO (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6</span></a>a). The network of miR-144-3p and target genes was made to show its potential function, revealing that many target genes of miR-144-3p enriched in immune-related signaling pathways (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6</span></a>b). Subsequently, we selected miR-144-3p for further analysis because miR-144-3p were upregulated in both Pla-Exos and PBMCs of active TAO patients (Figs.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>f and <a href="/pmc/articles/PMC11157872/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and6a),</span></span><span>6</span></a>a), which suggested that miR-144-3p may be a specific immunocyte-derived exosome-miRNA that could be responsible for exosome-induced Thy-1<sup>+</sup> OFs dysfunction.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC11157872/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697835628880"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figf_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figf_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figf_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697835628880"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><p>miR-144-3p expression was increased in PBMCs from patients with active TAO. <strong>(a)</strong> Levels of miR-134-5p, miR-144-3p, miR-431-5p and miR-483-3p in PBMCs determined by RT-PCR and normalized to the U6 expression levels. <strong>(b)</strong> miR-144-3p-target gene pathway network. Error bars represent the mean&#x02009;&#x000b1;&#x02009;SD. ns no significance, * <em>p</em>&#x02009;&#x0003c;&#x02009;0.05, student&#x02019;s <em>t</em> test. PBMCs peripheral blood mononuclear cells</p></div></div></div><p id="Par51" class="p p-last">

</p></div><div id="Sec25" class="sec sec-last"><h3 id="Sec25title">MiR&#x02011;144-3p induced proinflammatory cytokines and HA production in Thy-1<sup>+</sup> OFs</h3><p id="Par39" class="p p-first">To formally acquire mechanistic insights on miR-144-3p-specific role in OF activation and proliferation, a miRNA mimic-based analysis was performed. The miR-144-3p mimic and control mimic were transfected into Thy-1<sup>+</sup> OFs, and the potential direct/indirect target mRNAs (inflammatory molecules, HAS1, HAS2, HA) and cell proliferation were quantified. As shown in Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>, this analysis provided functional evidence recapitulating the exosome-based observations. The results were causally associated with the functional observations previously described, since previous reports have pinpointed miR-144-3p as a regulator of inflammatory makers [<a href="#CR27" rid="CR27" class=" bibr popnode">27</a>], fibrotic markers [<a href="#CR28" rid="CR28" class=" bibr popnode">28</a>], and cell proliferation [<a href="#CR29" rid="CR29" class=" bibr popnode">29</a>]. Consistent with the functional observations, treatment with miR-144-3p mimic significantly augmented the expression of inflammatory molecules (IL-1&#x003b2;, IL-6, TNF-&#x003b1;, CXCL2, RANTES) (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>a, b) and increased the levels of HA-associated proteins (HAS1, HA) (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>c, d). Compared to the control mimics, the proliferative ability of Thy-1<sup>+</sup> OFs was also inhibited by miR-144-3p mimics (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>e). Importantly, miR-144-3p inhibitors eliminated the antiproliferation, proinflammatory and profibrogenic effects in Thy-1<sup>+</sup> OFs (Fig.&#x000a0;<a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig7" rid-ob="ob-Fig7" co-legend-rid="lgnd_Fig7"><span>7</span></a>f, g and S5). Taken together, these data support the concept that treatment with the miR-144-3p mimic significantly induces stronger cytokine, HA production and attenuates cell proliferation in Thy-1<sup>+</sup> OFs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig7" co-legend-rid="lgnd_Fig7"><a href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140697857548288"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11157872_12967_2024_5263_Figg_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12967_2024_5263_Figg_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11157872/bin/12967_2024_5263_Figg_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140697857548288"><a target="object" rel="noopener" href="/pmc/articles/PMC11157872/figure/Fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig7"><div><a class="figpopup" href="/pmc/articles/PMC11157872/figure/Fig7/" target="figure" rid-figpopup="Fig7" rid-ob="ob-Fig7">Fig. 7</a></div><!--caption a7--><div class="caption"><p>miR-144-3p induced Thy-1<sup>+</sup> OFs dysfunction. <strong>(a, b)</strong> Levels of inflammatory molecules in Thy-1<sup>+</sup> OFs treated with miR-144-3p mimics or control mimics. <strong>(c, d)</strong> Levels of HAS and HA in Thy-1<sup>+</sup> OFs treated with miR-144-3p mimics or control mimics. <strong>(e)</strong> Cell proliferation of Thy-1<sup>+</sup> OFs treated with miR-144-3p mimics or control mimics. <strong>(f, g)</strong> Levels of inflammatory molecules in Thy-1<sup>+</sup> OFs treated with miR-144-3p inhibitors or control inhibitors. Error bars represent the mean&#x02009;&#x000b1;&#x02009;SD. <em>n</em>&#x02009;=&#x02009;6 per group. ns no significance, * <em>p</em>&#x02009;&#x0003c;&#x02009;0.05, ** <em>p</em>&#x02009;&#x0003c;&#x02009;0.01, *** <em>p</em>&#x02009;&#x0003c;&#x02009;0.001 and **** <em>p</em>&#x02009;&#x0003c;&#x02009;0.0001, student&#x02019;s <em>t</em> test</p></div></div></div><p id="Par52" class="p p-last">

</p></div></div><div id="Sec26" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec26title">Discussion</h2><p id="Par40" class="p p-first">The major outcome of this study provides evidence of the impact of plasma exosomes derived from patients with active TAO on orbital fibroblast activation. The comparison between Pla-Exos<sup>TAO&#x02212;A</sup> and Pla-Exos<sup>HC</sup> highlights the functional differences correlating with exosome structural properties. Functionally, Pla-Exos<sup>TAO&#x02212;A</sup> displays a proinflammatory and profibrotic ability (i.e., decrease of Thy-1<sup>+</sup> OFs pro-inflammatory and fibrogenic markers) that is lost in Pla-Exos<sup>HC</sup>; Pla-Exos<sup>TAO&#x02212;A</sup> inhibits Thy-1<sup>+</sup> OFs proliferation. These functional differences correlate with specific cargo signatures in terms of miRNAs and mRNAs.</p><p id="Par41">We provide the first evidence that active TAO-derived Pla-Exos can activate Thy-1<sup>+</sup> OFs to induce the expression of proinflammatory and fibrogenic markers. In addition, they were also found to inhibit proliferation in Thy-1<sup>+</sup> OFs. Exposure to Pla-Exos<sup>TAO&#x02212;A</sup> significantly upregulated the expression and secretion levels of proinflammatory factors (e.g., IL-1&#x003b2;&#x03001;IL-6&#x03001;TNF-&#x00251;&#x03001;CXCL2 and RANTES) in Thy-1<sup>+</sup> OFs compared with Pla-Exos<sup>HC</sup>. As a major inflammatory and fibrotic mediators, the upregulation of these cytokines and chemokines promotes immune cell recruitment to the orbital connective tissues [<a href="#CR30" rid="CR30" class=" bibr popnode">30</a>&#x02013;<a href="#CR32" rid="CR32" class=" bibr popnode">32</a>] and enhances HA accumulation in the extracellular matrix [<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>, <a href="#CR33" rid="CR33" class=" bibr popnode">33</a>, <a href="#CR34" rid="CR34" class=" bibr popnode">34</a>], which may be an important cause of constant inflammation and fibrosis in TAO. Similarly, previous studies have confirmed that circulating exosomes derived from patients with Graves&#x02019; disease [<a href="#CR35" rid="CR35" class=" bibr popnode">35</a>] or active SLE [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>] have immunological activity to induce PBMCs to secrete more inflammatory cytokines [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>]. Additionally, Hijmans et al. [<a href="#CR36" rid="CR36" class=" bibr popnode">36</a>] also identified that HIV patients derived Pla-Exos induced proinflammatory immune response and apoptosis of endothelial cells, which may be related to the increased incidence of cardiovascular diseases in patients. Critically, a recent study on HCV highlighted that fibrogenic signals persist in EVs derived from plasma and are conceivably causal for long-term liver disease progression in patients with HCV [<a href="#CR16" rid="CR16" class=" bibr popnode">16</a>]. Hence, our data suggest that Pla-Exos<sup>TAO&#x02212;A</sup> has proinflammatory activity, thereby participating in the immunologic derangement and fibrosis process of TAO.</p><p id="Par42">Exosomes are known to have similar contents and functions as their source cells, because exosomes contain a unique signature of nucleic acids, proteins and lipids, reflecting their cell and tissue of origin [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR13" rid="CR13" class=" bibr popnode">13</a>, <a href="#CR37" rid="CR37" class=" bibr popnode">37</a>]. With respect to exosome mRNA cargo, the ssGSEA results showed that Th1 cell marker genes were upregulated in Pla-Exos<sup>TAO&#x02212;A</sup>, consistent with a systematic review study conducted by Fang, et al., in which they suggested that Th1 immune response predominates in the TAO autoimmunity, especially in early active phase [<a href="#CR7" rid="CR7" class=" bibr popnode">7</a>]. At the same time, the marker genes of DC and NK cells were found to downregulate in Pla-Exos<sup>TAO&#x02212;A</sup>. A previous study showed that mDCs are negatively related to TAO incidence [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>]. In inflammatory/autoimmune diseases, immune cells (e.g., T cells, B cells, and monocytes) activate and release inflammatory exosomes, and these inflammatory exosomes also play a key role in physiological and pathological processes, such as immune response, antigen presentation, and immune cell differentiation [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>, <a href="#CR39" rid="CR39" class=" bibr popnode">39</a>, <a href="#CR40" rid="CR40" class=" bibr popnode">40</a>]. Circulating T cells abnormally activate in active TAO and are associated with TAO activity [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>, <a href="#CR41" rid="CR41" class=" bibr popnode">41</a>, <a href="#CR42" rid="CR42" class=" bibr popnode">42</a>]. Hence, T cells-derived exosomes in patients with active TAO may also be immunologically active and play an important role in the progression of inflammation and fibrosis. The mRNA of the exosomes reflects the mRNA of the originating cell, so we speculate that the functional difference in Pla-Exos contents and functions between HC and TAO may be due to the changes in circulating immune cell profiles.</p><p id="Par43">We identify miR-144-3p as an immune cell-derived molecule in Pla-Exos that induces Thy-1<sup>+</sup> OFs dysfunction. Although exosomes contain various proteins and lipids, they are highly enriched in noncoding mRNAs, particularly miRNAs [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR43" rid="CR43" class=" bibr popnode">43</a>]. Exosomes exert their biological actions mainly through their contained miRNAs. Our data highlights that a total of 107 DE-miRNAs that were detected between TAO-A and HC groups. KEGG analysis showed that the target genes of the DE-miRs are mainly enriched in immune response and cell adhesion, which is consistent with the functions of the Pla-Exos. In line with previous reports, our data showed that the main pathological changes in the active phase of TAO are abnormal immune responses [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>, <a href="#CR32" rid="CR32" class=" bibr popnode">32</a>, <a href="#CR44" rid="CR44" class=" bibr popnode">44</a>&#x02013;<a href="#CR46" rid="CR46" class=" bibr popnode">46</a>]. RT-qPCR results confirmed that the expression levels of the four exosome-miRNAs (miR-134-5p, miR-144-3p, miR-431-5p and miR-483-3p) were upregulated in patients with active TAO compared to HCs. Their expression levels were further determined in PBMCs to select functional miRNAs derived from immune cells, and the results showed that miR-144-3p was upregulated in TAO-A-PBMCs. Based on these results, we speculate that the upregulated miR-144-3p in Pla-Exos include those of immune cell origin. Surprisingly, we observed no overlap in the specific miRNAs in PBMCs identified by Liu et al., who did not find changes in miR-144 [<a href="#CR47" rid="CR47" class=" bibr popnode">47</a>]. Among the identified miRNAs, miR-144-3p was most notable as it has been thoroughly investigated and associated with inflammatory response and fibrosis [<a href="#CR27" rid="CR27" class=" bibr popnode">27</a>, <a href="#CR28" rid="CR28" class=" bibr popnode">28</a>, <a href="#CR48" rid="CR48" class=" bibr popnode">48</a>, <a href="#CR49" rid="CR49" class=" bibr popnode">49</a>]. Thus, miR-144-3p was a candidate mediator of the Thy-1<sup>+</sup> OFs dysfunction. By means of a mimic-based approach, we provided evidence to miR-144-3p inducing Thy-1<sup>+</sup> OFs dysfunction; specifically, we demonstrated that miR-144-3p exert proinflammatory and fibrogenic effects and inhibit cell viability of Thy-1<sup>+</sup> OFs. Our findings are in tandem with those of Chen et al. [<a href="#CR27" rid="CR27" class=" bibr popnode">27</a>], who demonstrated that upregulation of serum exosomal miR-144-3p as a reliable biomarker of mucosal inflammation in Crohn&#x02019;s disease (CD), abolished cell viability of human umbilical vein endothelial cells [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>]. An emerging study has provided clues that miR-144-3p also enhances cytokine expression in human synovial fibroblasts [<a href="#CR49" rid="CR49" class=" bibr popnode">49</a>]. Previous studies have shown that miR-144-3p can inhibit cell proliferation [<a href="#CR48" rid="CR48" class=" bibr popnode">48</a>, <a href="#CR50" rid="CR50" class=" bibr popnode">50</a>]. To the best of our knowledge, the present study is the first to identify a novel miRNA enriched in Pla-Exos, providing a basis for the therapeutic application of the plasma exosomes in active TAO.</p><p id="Par44" class="p p-last">One limitation of our study was the relatively low sample number, only 25 samples were enrolled for validation, and most of these cases were male (80%), however, the incidence of TAO is significantly lower in males than in females, which may be an additional drawback. Therefore, a large population of active TAO patients will be needed to obtain conclusive evidence of our findings in the future. In addition, in vivo studies have been lacking but are necessary, given the interplay between the different components of the circulatory system and its interaction with different organs in the body. Measuring functional changes in vivo, such as these, is complicated by limited blood volume from patients and the ethical issues associated with rapid, repeated sampling in patients. Critically, further studies will be required to identify the molecular mechanisms underlying the inflammatory and fibrotic effects of Pla-Exos; and the protein cargo will require further analysis because the RNA cargos analysis does not fully explain the function of Pla-Exos function, while proteins may provide more clues to the mechanisms of Pla-Exos action.</p></div><div id="Sec27" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec27title">Conclusion</h2><p id="Par45" class="p p-first-last">In summary, we identified that active TAO-derived plasma exosomes are immune-active for their structural modifications. The structural modifications (such as up-regulation of miR-144-3p) of exosomes are conceivably causal for the long-term inflammatory and fibrosis progression in patients with TAO. Evidence has revealed that the orbital inflammation and fibrosis process is not unidirectional and permanent in TAO. Currently, there are no &#x0201c;gold standard&#x0201d; therapies for orbital tissue fibrosis, and intravenous corticosteroids are considered the first-line therapy as highlighted by inflammation resolution which can ameliorate orbital fibrosis. In this context, enhancing the clearance of immune-active plasma exosomes or inhibiting the bioactive molecules in plasma exosomes may represent an effective approach for managing active TAO.</p></div><div id="sec-a.p.f" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="headless nomenu"></h2><!--/article/body/sec/--><div id="Sec28" class="sec sec-first-last"><h3 id="Sec28title">Electronic supplementary material</h3><p class="p p-first">Below is the link to the electronic supplementary material.</p><p>
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.p.f.a.c.a.a"><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">Supplementary Material 1</a><sup>(16K, docx)</sup></div></div><p>
</p><p>
</p><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="media-a.p.f.a.d.a.a"><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM2_ESM.docx" data-ga-action="click_feat_suppl">Supplementary Material 2</a><sup>(31K, docx)</sup></div></div><p>
</p><p>
</p><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="media-a.p.f.a.e.a.a"><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM3_ESM.docx" data-ga-action="click_feat_suppl">Supplementary Material 3</a><sup>(1.1M, docx)</sup></div></div><p>
</p><p class="p p-last">
</p><div class="sec suppmat" id="MOESM4"><div class="sup-box half_rhythm" id="media-a.p.f.a.f.a.a"><a href="/pmc/articles/PMC11157872/bin/12967_2024_5263_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Supplementary Material 4</a><sup>(27M, pdf)</sup></div></div><p>
</p></div></div><div id="ack-a.q.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.q.btitle">Acknowledgements</h2><div class="sec"><p>We thank participants for their involvement for help with collecting and recording clinical information. We also thank EchoBiotech Co. Ltd in Beijing for technical support and kind assistance with analysis.</p></div></div><div id="notes-a.q.c" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.ctitle">Author contributions</h2><p>W.W., Z.L.C. and L.W. designed the study. Y.T., S.S.,B.Y., Q.H, L.C., Z.L., X.H. and W.L. were involved in patient recruitment and sample acquisition. L.W., Q.Y.H., S.S., X.Z., B.Y., Q.H., L.C., Y.L., Z.L., L.B., S.X., L.T. and X.L. performed experiments. W.L., Q.Y.H., Y.T., and S.S. performed data analyses and wrote the manuscript with advice and feedback from all authors. W.W. is responsible for the overall content as a guarantor. All authors critically revised the manuscript and gave final approval to the version submitted for publication.</p></div><div id="notes-a.q.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.dtitle">Funding</h2><p>This study was supported by the National Key R&#x00026;D Program of China (2021YFA1101200), the National Natural Science Foundation of China (82171048), the Key R&#x00026;D Program of Zhejiang Province (2021C03065), and the Key R&#x00026;D Program of Wenzhou Eye Hospital (YNZD1201902).</p></div><div id="notes-a.q.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.etitle">Data availability</h2><p>The raw sequence data have been deposited in the Genome Sequence Archive in National Genomics Data Center, China National Center for Bioinformation / Beijing Institute of Genomics, Chinese Academy of Sciences (GSA-Human: HRA006037) that are publicly accessible in Gene Expression Omnibus (GEO). Any additional information required to reanalyze the data reported in this paper is available from the corresponding author.</p></div><div id="notes-a.q.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.q.ftitle">Declarations</h2><div>Ethics approval and consent to participate<p id="Par65">All procedures involving human participants were carried out in accordance with the ethical standards of the Ethics Committee of the Eye Hospital of Wenzhou Medical University, Wenzhou, China (2022-109-K-83) and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in the study.</p></div><div>Consent for publication<p id="Par66">Not applicable.</p></div><div>Conflict of interest<p id="Par67">The authors declare no competing interests.</p></div></div><div id="fn-group-a.q.a" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.q.atitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.q.a.a"><p class="p p-first"><strong>Publisher&#x02019;s Note</strong></p><p class="p p-last">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p><p class="fn sec" id="fn-a.q.a.b"><p class="p p-first-last">Li Wei, Qinying Huang and Yunhai Tu contributed equally to this work.</p></p></div></div><div id="article-aaff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="article-aaff-infotitle">Contributor Information</h2><p><span class="fm-affl">Zai-Long Chi, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.ca.eye@ihc.gnoliaz" class="oemail">nc.ca.eye@ihc.gnoliaz</a></span>.</p><p><span class="fm-affl">Wencan Wu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@8311nacnewuw" class="oemail">moc.361@8311nacnewuw</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Bartalena L, Tanda ML. Clinical practice. Graves&#x02019; ophthalmopathy. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>(10):994–1001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19264688" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Clinical+practice.+Graves&#x02019;+ophthalmopathy&amp;author=L+Bartalena&amp;author=ML+Tanda&amp;volume=360&amp;issue=10&amp;publication_year=2009&amp;pages=994-1001&amp;pmid=19264688&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2018;<span class="ref-vol">14</span>(5):301–16.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29569622" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Endocrinol&amp;title=Global+epidemiology+of+hyperthyroidism+and+hypothyroidism&amp;author=PN+Taylor&amp;author=D+Albrecht&amp;author=A+Scholz&amp;author=G+Gutierrez-Buey&amp;author=JH+Lazarus&amp;volume=14&amp;issue=5&amp;publication_year=2018&amp;pages=301-16&amp;pmid=29569622&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Krieger CC, Place RF, Bevilacqua C, Marcus-Samuels B, Abel BS, Skarulis MC, et al. TSH/IGF-1 receptor Cross Talk in Graves&#x02019; Ophthalmopathy Pathogenesis. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2016;<span class="ref-vol">101</span>(6):2340–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4891793/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27043163" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=TSH/IGF-1+receptor+Cross+Talk+in+Graves&#x02019;+Ophthalmopathy+Pathogenesis&amp;author=CC+Krieger&amp;author=RF+Place&amp;author=C+Bevilacqua&amp;author=B+Marcus-Samuels&amp;author=BS+Abel&amp;volume=101&amp;issue=6&amp;publication_year=2016&amp;pages=2340-7&amp;pmid=27043163&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM, et al. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2020;<span class="ref-vol">16</span>(2):104–16.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31889140" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Endocrinol&amp;title=New+insights+into+the+pathogenesis+and+nonsurgical+management+of+Graves+orbitopathy&amp;author=PN+Taylor&amp;author=L+Zhang&amp;author=RWJ+Lee&amp;author=I+Muller&amp;author=DG+Ezra&amp;volume=16&amp;issue=2&amp;publication_year=2020&amp;pages=104-16&amp;pmid=31889140&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves&#x02019; orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves&#x02019; orbitopathy. <span><span class="ref-journal">Eur J Endocrinol. </span>2021;<span class="ref-vol">185</span>(4):G43–67.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34297684" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Endocrinol&amp;title=The+2021+European+Group+on+Graves&#x02019;+orbitopathy+(EUGOGO)+clinical+practice+guidelines+for+the+medical+management+of+Graves&#x02019;+orbitopathy&amp;author=L+Bartalena&amp;author=GJ+Kahaly&amp;author=L+Baldeschi&amp;author=CM+Dayan&amp;author=A+Eckstein&amp;volume=185&amp;issue=4&amp;publication_year=2021&amp;pages=G43-67&amp;pmid=34297684&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, et al. Association of T and B Cells Infiltrating Orbital Tissues with clinical features of Graves Orbitopathy. <span><span class="ref-journal">JAMA Ophthalmol. </span>2018;<span class="ref-vol">136</span>(6):613–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6583879/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29710102" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA+Ophthalmol&amp;title=Association+of+T+and+B+Cells+Infiltrating+Orbital+Tissues+with+clinical+features+of+Graves+Orbitopathy&amp;author=G+Rotondo+Dottore&amp;author=L+Torregrossa&amp;author=P+Caturegli&amp;author=I+Ionni&amp;author=A+Sframeli&amp;volume=136&amp;issue=6&amp;publication_year=2018&amp;pages=613-9&amp;pmid=29710102&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Fang S, Lu Y, Huang Y, Zhou H, Fan X. Mechanisms that underly T cell immunity in Graves&#x02019; Orbitopathy. <span><span class="ref-journal">Front Endocrinol (Lausanne) </span>2021;<span class="ref-vol">12</span>:648732.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8049604/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33868176" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Endocrinol+(Lausanne)&amp;title=Mechanisms+that+underly+T+cell+immunity+in+Graves&#x02019;+Orbitopathy&amp;author=S+Fang&amp;author=Y+Lu&amp;author=Y+Huang&amp;author=H+Zhou&amp;author=X+Fan&amp;volume=12&amp;publication_year=2021&amp;pages=648732&amp;pmid=33868176&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">van Steensel L, Paridaens D, van Meurs M, et al. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves&#x02019; ophthalmopathy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>(3):E400–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22238384" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Orbit-infiltrating+mast+cells,+monocytes,+and+macrophages+produce+PDGF+isoforms+that+orchestrate+orbital+fibroblast+activation+in+Graves&#x02019;+ophthalmopathy&amp;author=L+van+Steensel&amp;author=D+Paridaens&amp;author=M+van+Meurs&amp;volume=97&amp;issue=3&amp;publication_year=2012&amp;pages=E400-8&amp;pmid=22238384&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ, et al. Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. <span><span class="ref-journal">Invest Ophthalmol Vis Sci. </span>2009;<span class="ref-vol">50</span>(5):2262–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2752347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19117935" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Orbital+fibroblasts+from+patients+with+thyroid-associated+ophthalmopathy+overexpress+CD40:+CD154+hyperinduces+IL-6,+IL-8,+and+MCP-1&amp;author=CJ+Hwang&amp;author=N+Afifiyan&amp;author=D+Sand&amp;author=V+Naik&amp;author=J+Said&amp;volume=50&amp;issue=5&amp;publication_year=2009&amp;pages=2262-8&amp;pmid=19117935&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Buzas EI, Gy&#x000f6;rgy B, Nagy G, Falus A, Gay S. Emerging role of extracellular vesicles in inflammatory diseases. <span><span class="ref-journal">Nat Rev Rheumatol. </span>2014;<span class="ref-vol">10</span>(6):356–64.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24535546" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Rheumatol&amp;title=Emerging+role+of+extracellular+vesicles+in+inflammatory+diseases&amp;author=EI+Buzas&amp;author=B+Gy&#x000f6;rgy&amp;author=G+Nagy&amp;author=A+Falus&amp;author=S+Gay&amp;volume=10&amp;issue=6&amp;publication_year=2014&amp;pages=356-64&amp;pmid=24535546&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="mixed-citation">Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7717626/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32029601" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Jeppesen DK, Fenix AM, Franklin JL, et al. <span><span class="ref-journal">Reassessment Exosome Composition Cell. </span>2019;<span class="ref-vol">177</span>(2):428–e44518.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6664447/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30951670" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Reassessment+Exosome+Composition+Cell&amp;author=DK+Jeppesen&amp;author=AM+Fenix&amp;author=JL+Franklin&amp;volume=177&amp;issue=2&amp;publication_year=2019&amp;pages=428-e44518&amp;pmid=30951670&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Yates AG, Pink RC, Erdbr&#x000fc;gger U, Siljander PR, Dellar ER, Pantazi P, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: part II: Pathology: part II: Pathology. <span><span class="ref-journal">J Extracell Vesicles. </span>2022;<span class="ref-vol">11</span>(1):e12190.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8765328/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35041301" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Extracell+Vesicles&amp;title=In+sickness+and+in+health:+the+functional+role+of+extracellular+vesicles+in+physiology+and+pathology+in+vivo:+part+II:+Pathology:+part+II:+Pathology&amp;author=AG+Yates&amp;author=RC+Pink&amp;author=U+Erdbr&#x000fc;gger&amp;author=PR+Siljander&amp;author=ER+Dellar&amp;volume=11&amp;issue=1&amp;publication_year=2022&amp;pages=e12190&amp;pmid=35041301&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Ismail N, Wang Y, Dakhlallah D, Moldovan L, Agarwal K, Batte K, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>(6):984–95.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3567345/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23144169" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Macrophage+microvesicles+induce+macrophage+differentiation+and+miR-223+transfer&amp;author=N+Ismail&amp;author=Y+Wang&amp;author=D+Dakhlallah&amp;author=L+Moldovan&amp;author=K+Agarwal&amp;volume=121&amp;issue=6&amp;publication_year=2013&amp;pages=984-95&amp;pmid=23144169&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Lee JY, Park JK, Lee EY, Lee EB, Song YW. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response. <span><span class="ref-journal">Arthritis Res Ther. </span>2016;<span class="ref-vol">18</span>(1):264.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5112700/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27852323" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Res+Ther&amp;title=Circulating+exosomes+from+patients+with+systemic+lupus+erythematosus+induce+an+proinflammatory+immune+response&amp;author=JY+Lee&amp;author=JK+Park&amp;author=EY+Lee&amp;author=EB+Lee&amp;author=YW+Song&amp;volume=18&amp;issue=1&amp;publication_year=2016&amp;pages=264&amp;pmid=27852323&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, D&#x02019;Offizi G, et al. Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response. <span><span class="ref-journal">J Hepatol. </span>2021;<span class="ref-vol">75</span>(6):1301–11.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34271004" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Fibrogenic+signals+persist+in+DAA-treated+HCV+patients+after+sustained+virological+response&amp;author=C+Montaldo&amp;author=M+Terri&amp;author=V+Riccioni&amp;author=C+Battistelli&amp;author=V+Bordoni&amp;volume=75&amp;issue=6&amp;publication_year=2021&amp;pages=1301-11&amp;pmid=34271004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Liu X, Yuan J, Wu Z, Zhang J, Shen Y, Jia J. Plasma exosome miRNA-26b-3p derived from idiopathic short stature impairs longitudinal bone growth via the AKAP2/ERK1/2 axis. <span><span class="ref-journal">J Nanobiotechnol. </span>2023;<span class="ref-vol">21</span>(1):94.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10022307/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36927779" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Nanobiotechnol&amp;title=Plasma+exosome+miRNA-26b-3p+derived+from+idiopathic+short+stature+impairs+longitudinal+bone+growth+via+the+AKAP2/ERK1/2+axis&amp;author=X+Liu&amp;author=J+Yuan&amp;author=Z+Wu&amp;author=J+Zhang&amp;author=Y+Shen&amp;volume=21&amp;issue=1&amp;publication_year=2023&amp;pages=94&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Hiratsuka I, Yamada H, Munetsuna E, Hashimoto S, Itoh M. Circulating MicroRNAs in Graves&#x02019; Disease in relation to clinical activity. <span><span class="ref-journal">Thyroid. </span>2016;<span class="ref-vol">26</span>(10):1431–40.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27610819" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid&amp;title=Circulating+MicroRNAs+in+Graves&#x02019;+Disease+in+relation+to+clinical+activity&amp;author=I+Hiratsuka&amp;author=H+Yamada&amp;author=E+Munetsuna&amp;author=S+Hashimoto&amp;author=M+Itoh&amp;volume=26&amp;issue=10&amp;publication_year=2016&amp;pages=1431-40&amp;pmid=27610819&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Bartley GB, Gorman CA. Diagnostic criteria for Graves&#x02019; ophthalmopathy. <span><span class="ref-journal">Am J Ophthalmol. </span>1995;<span class="ref-vol">119</span>(6):792–5.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7785696" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Ophthalmol&amp;title=Diagnostic+criteria+for+Graves&#x02019;+ophthalmopathy&amp;author=GB+Bartley&amp;author=CA+Gorman&amp;volume=119&amp;issue=6&amp;publication_year=1995&amp;pages=792-5&amp;pmid=7785696&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves&#x02019; ophthalmopathy: a novel approach. <span><span class="ref-journal">Br J Ophthalmol. </span>1989;<span class="ref-vol">73</span>(8):639–44.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1041835/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2765444" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Ophthalmol&amp;title=Clinical+criteria+for+the+assessment+of+disease+activity+in+Graves&#x02019;+ophthalmopathy:+a+novel+approach&amp;author=MP+Mourits&amp;author=L+Koornneef&amp;author=WM+Wiersinga&amp;author=MF+Prummel&amp;author=A+Berghout&amp;volume=73&amp;issue=8&amp;publication_year=1989&amp;pages=639-44&amp;pmid=2765444&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Guan JT, Li XX, Peng DW, Zhang WM, Qu J, Lu F, et al. MicroRNA-18a-5p administration suppresses retinal neovascularization by targeting FGF1 and HIF1A. <span><span class="ref-journal">Front Pharmacol. </span>2020;<span class="ref-vol">11</span>:276.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7076186/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32210827" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Pharmacol&amp;title=MicroRNA-18a-5p+administration+suppresses+retinal+neovascularization+by+targeting+FGF1+and+HIF1A&amp;author=JT+Guan&amp;author=XX+Li&amp;author=DW+Peng&amp;author=WM+Zhang&amp;author=J+Qu&amp;volume=11&amp;publication_year=2020&amp;pages=276&amp;pmid=32210827&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">462</span>(7269):108–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2783335/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19847166" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Systematic+RNA+interference+reveals+that+oncogenic+KRAS-driven+cancers+require+TBK1&amp;author=DA+Barbie&amp;author=P+Tamayo&amp;author=JS+Boehm&amp;author=SY+Kim&amp;author=SE+Moody&amp;volume=462&amp;issue=7269&amp;publication_year=2009&amp;pages=108-12&amp;pmid=19847166&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. <span><span class="ref-journal">Cell Rep. </span>2017;<span class="ref-vol">18</span>(1):248–62.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28052254" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep&amp;title=Pan-cancer+immunogenomic+analyses+reveal+genotype-immunophenotype+relationships+and+predictors+of+response+to+checkpoint+blockade&amp;author=P+Charoentong&amp;author=F+Finotello&amp;author=M+Angelova&amp;author=C+Mayer&amp;author=M+Efremova&amp;volume=18&amp;issue=1&amp;publication_year=2017&amp;pages=248-62&amp;pmid=28052254&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Ma L, Wang L, Khatib SA, Chang CW, Heinrich S, Dominguez DA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. <span><span class="ref-journal">J Hepatol. </span>2021;<span class="ref-vol">75</span>(6):1397–408.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8604764/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34216724" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Single-cell+atlas+of+tumor+cell+evolution+in+response+to+therapy+in+hepatocellular+carcinoma+and+intrahepatic+cholangiocarcinoma&amp;author=L+Ma&amp;author=L+Wang&amp;author=SA+Khatib&amp;author=CW+Chang&amp;author=S+Heinrich&amp;volume=75&amp;issue=6&amp;publication_year=2021&amp;pages=1397-408&amp;pmid=34216724&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, et al. Plasma extracellular RNA profiles in healthy and cancer patients. <span><span class="ref-journal">Sci Rep. </span>2016;<span class="ref-vol">6</span>:19413.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4726401/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26786760" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Plasma+extracellular+RNA+profiles+in+healthy+and+cancer+patients&amp;author=T+Yuan&amp;author=X+Huang&amp;author=M+Woodcock&amp;author=M+Du&amp;author=R+Dittmar&amp;volume=6&amp;publication_year=2016&amp;pages=19413&amp;pmid=26786760&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Douglas RS, Gianoukakis AG, Goldberg RA, Kamat S, Smith TJ. Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes. <span><span class="ref-journal">Clin Exp Immunol. </span>2007;<span class="ref-vol">148</span>(1):64–71.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1868859/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17349012" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=Circulating+mononuclear+cells+from+euthyroid+patients+with+thyroid-associated+ophthalmopathy+exhibit+characteristic+phenotypes&amp;author=RS+Douglas&amp;author=AG+Gianoukakis&amp;author=RA+Goldberg&amp;author=S+Kamat&amp;author=TJ+Smith&amp;volume=148&amp;issue=1&amp;publication_year=2007&amp;pages=64-71&amp;pmid=17349012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Chen P, Huang S, Yu Q, Chao K, Wang Y, Zhou G, et al. Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn&#x02019;s disease. <span><span class="ref-journal">Gastroenterol Rep (Oxf) </span>2022;<span class="ref-vol">10</span>:goab056.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8973006/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35382172" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gastroenterol+Rep+(Oxf)&amp;title=Serum+exosomal+microRNA-144-3p:+a+promising+biomarker+for+monitoring+Crohn&#x02019;s+disease&amp;author=P+Chen&amp;author=S+Huang&amp;author=Q+Yu&amp;author=K+Chao&amp;author=Y+Wang&amp;volume=10&amp;publication_year=2022&amp;pages=goab056&amp;pmid=35382172&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Bahudhanapati H, Tan J, Dutta JA, Strock SB, Sembrat J, &#x000c0;lvarez D, et al. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis. <span><span class="ref-journal">J Biol Chem. </span>2019;<span class="ref-vol">294</span>(13):5008–22.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6442041/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30709904" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=MicroRNA-144-3p+targets+relaxin/insulin-like+family+peptide+receptor+1+(RXFP1)+expression+in+lung+fibroblasts+from+patients+with+idiopathic+pulmonary+fibrosis&amp;author=H+Bahudhanapati&amp;author=J+Tan&amp;author=JA+Dutta&amp;author=SB+Strock&amp;author=J+Sembrat&amp;volume=294&amp;issue=13&amp;publication_year=2019&amp;pages=5008-22&amp;pmid=30709904&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated mir-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. <span><span class="ref-journal">Mol Cancer. </span>2023;<span class="ref-vol">22</span>(1):113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC10351131/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37461104" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer&amp;title=Exosome-mediated+mir-144-3p+promotes+ferroptosis+to+inhibit+osteosarcoma+proliferation,+migration,+and+invasion+through+regulating+ZEB1&amp;author=M+Jiang&amp;author=Y+Jike&amp;author=K+Liu&amp;author=F+Gan&amp;author=K+Zhang&amp;volume=22&amp;issue=1&amp;publication_year=2023&amp;pages=113&amp;pmid=37461104&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Chen B, Tsui S, Smith TJ. IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">175</span>(2):1310–9.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16002736" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=IL-1+beta+induces+IL-6+expression+in+human+orbital+fibroblasts:+identification+of+an+anatomic-site+specific+phenotypic+attribute+relevant+to+thyroid-associated+ophthalmopathy&amp;author=B+Chen&amp;author=S+Tsui&amp;author=TJ+Smith&amp;volume=175&amp;issue=2&amp;publication_year=2005&amp;pages=1310-9&amp;pmid=16002736&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Elner VM, Burnstine MA, Kunkel SL, Strieter RM, Elner SG. Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts. <span><span class="ref-journal">Ophthalmic Plast Reconstr Surg. </span>1998;<span class="ref-vol">14</span>(2):119–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9558669" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic+Plast+Reconstr+Surg&amp;title=Interleukin-8+and+monocyte+chemotactic+protein-1+gene+expression+and+protein+production+by+human+orbital+fibroblasts&amp;author=VM+Elner&amp;author=MA+Burnstine&amp;author=SL+Kunkel&amp;author=RM+Strieter&amp;author=SG+Elner&amp;volume=14&amp;issue=2&amp;publication_year=1998&amp;pages=119-25&amp;pmid=9558669&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="mixed-citation">G&#x000f6;rtz GE, Philipp S, Bruderek K, Jesenek C, Horstmann M, Henning Y et al. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves&#x02019; Orbitopathy. Endocrinology. 2022;164(2). [<a href="https://pubmed.ncbi.nlm.nih.gov/36477465" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps RP, Smith TJ. Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>(45):29615–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9792671" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Activation+of+human+orbital+fibroblasts+through+CD40+engagement+results+in+a+dramatic+induction+of+hyaluronan+synthesis+and+prostaglandin+endoperoxide+H+synthase-2+expression.+Insights+into+potential+pathogenic+mechanisms+of+thyroid-associated+ophthalmopathy&amp;author=HJ+Cao&amp;author=HS+Wang&amp;author=Y+Zhang&amp;author=HY+Lin&amp;author=RP+Phipps&amp;volume=273&amp;issue=45&amp;publication_year=1998&amp;pages=29615-25&amp;pmid=9792671&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Guo N, Baglole CJ, O&#x02019;Loughlin CW, Feldon SE, Phipps RP. Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>(21):15794–804.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2871447/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20308056" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Mast+cell-derived+prostaglandin+D2+controls+hyaluronan+synthesis+in+human+orbital+fibroblasts+via+DP1+activation:+implications+for+thyroid+eye+disease&amp;author=N+Guo&amp;author=CJ+Baglole&amp;author=CW+O&#x02019;Loughlin&amp;author=SE+Feldon&amp;author=RP+Phipps&amp;volume=285&amp;issue=21&amp;publication_year=2010&amp;pages=15794-804&amp;pmid=20308056&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="mixed-citation">Cui X, Huang M, Wang S, Zhao N, Huang T, Wang Z et al. Circulating Exosomes from Patients With Graves&#x02019; Disease Induce an Inflammatory Immune Response. Endocrinology. 2021;162(3). [<a href="https://pubmed.ncbi.nlm.nih.gov/33367747" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Hijmans JG, Stockelman KA, Garcia V, Levy MV, Brewster LM, Bammert TD, et al. Circulating microparticles are elevated in treated HIV &#x02013;&#x02009;1 infection and are deleterious to endothelial cell function. <span><span class="ref-journal">J Am Heart Assoc. </span>2019;<span class="ref-vol">8</span>(4):e011134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6405669/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30779672" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Heart+Assoc&amp;title=Circulating+microparticles+are+elevated+in+treated+HIV+&#x02013;&#x02009;1+infection+and+are+deleterious+to+endothelial+cell+function&amp;author=JG+Hijmans&amp;author=KA+Stockelman&amp;author=V+Garcia&amp;author=MV+Levy&amp;author=LM+Brewster&amp;volume=8&amp;issue=4&amp;publication_year=2019&amp;pages=e011134&amp;pmid=30779672&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Yates AG, Pink RC, Erdbr&#x000fc;gger U, Siljander PR, Dellar ER, Pantazi P, et al. In sickness and in health: the functional role of extracellular vesicles in physiology and pathology in vivo: part I: Health and normal physiology: part I: Health and normal physiology. <span><span class="ref-journal">J Extracell Vesicles. </span>2022;<span class="ref-vol">11</span>(1):e12151.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8765331/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35041249" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Extracell+Vesicles&amp;title=In+sickness+and+in+health:+the+functional+role+of+extracellular+vesicles+in+physiology+and+pathology+in+vivo:+part+I:+Health+and+normal+physiology:+part+I:+Health+and+normal+physiology&amp;author=AG+Yates&amp;author=RC+Pink&amp;author=U+Erdbr&#x000fc;gger&amp;author=PR+Siljander&amp;author=ER+Dellar&amp;volume=11&amp;issue=1&amp;publication_year=2022&amp;pages=e12151&amp;pmid=35041249&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Wojciechowska-Durczynska K, Wieczorek-Szukala K, Stefanski B, Zygmunt A, Stepniak J, Karbownik-Lewinska M, et al. Percentage of myeloid dendritic cells in peripheral venous blood is negatively related to incidence of Graves&#x02019; Orbitopathy. <span><span class="ref-journal">Mediators Inflamm. </span>2021;<span class="ref-vol">2021</span>:8896055.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7857924/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33574732" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mediators+Inflamm&amp;title=Percentage+of+myeloid+dendritic+cells+in+peripheral+venous+blood+is+negatively+related+to+incidence+of+Graves&#x02019;+Orbitopathy&amp;author=K+Wojciechowska-Durczynska&amp;author=K+Wieczorek-Szukala&amp;author=B+Stefanski&amp;author=A+Zygmunt&amp;author=J+Stepniak&amp;volume=2021&amp;publication_year=2021&amp;pages=8896055&amp;pmid=33574732&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Zhou X, Xie F, Wang L, Zhang L, Zhang S, Fang M, et al. The function and clinical application of extracellular vesicles in innate immune regulation. <span><span class="ref-journal">Cell Mol Immunol. </span>2020;<span class="ref-vol">17</span>(4):323–34.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109106/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32203193" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Immunol&amp;title=The+function+and+clinical+application+of+extracellular+vesicles+in+innate+immune+regulation&amp;author=X+Zhou&amp;author=F+Xie&amp;author=L+Wang&amp;author=L+Zhang&amp;author=S+Zhang&amp;volume=17&amp;issue=4&amp;publication_year=2020&amp;pages=323-34&amp;pmid=32203193&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Rossaint J, K&#x000fc;hne K, Skupski J, Van Aken H, Looney MR, Hidalgo A, et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. <span><span class="ref-journal">Nat Commun. </span>2016;<span class="ref-vol">7</span>:13464.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5116072/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27845343" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Commun&amp;title=Directed+transport+of+neutrophil-derived+extracellular+vesicles+enables+platelet-mediated+innate+immune+response&amp;author=J+Rossaint&amp;author=K+K&#x000fc;hne&amp;author=J+Skupski&amp;author=H+Van+Aken&amp;author=MR+Looney&amp;volume=7&amp;publication_year=2016&amp;pages=13464&amp;pmid=27845343&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Vaidya B, Shenton BK, Stamp S, Miller M, Baister E, Andrews CD, et al. Analysis of peripheral blood T-cell subsets in active thyroid-associated ophthalmopathy: absence of effect of octreotide-LAR on T-cell subsets in patients with thyroid-associated ophthalmopathy. <span><span class="ref-journal">Thyroid. </span>2005;<span class="ref-vol">15</span>(9):1073–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16187917" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Thyroid&amp;title=Analysis+of+peripheral+blood+T-cell+subsets+in+active+thyroid-associated+ophthalmopathy:+absence+of+effect+of+octreotide-LAR+on+T-cell+subsets+in+patients+with+thyroid-associated+ophthalmopathy&amp;author=B+Vaidya&amp;author=BK+Shenton&amp;author=S+Stamp&amp;author=M+Miller&amp;author=E+Baister&amp;volume=15&amp;issue=9&amp;publication_year=2005&amp;pages=1073-8&amp;pmid=16187917&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Li H, Wang B, Li Q, Li Q, Qiao J, Lin D, et al. T cell subsets are Associated with clinical activity and efficacy of 4.5&#x000a0;g intravenous glucocorticoid for Moderate-To-Severe thyroid-Associated Ophthalmopathy. <span><span class="ref-journal">Endocr Res. </span>2023;<span class="ref-vol">48</span>(2&#x02013;3):55–67.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37345481" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Res&amp;title=T+cell+subsets+are+Associated+with+clinical+activity+and+efficacy+of+4.5&#x000a0;g+intravenous+glucocorticoid+for+Moderate-To-Severe+thyroid-Associated+Ophthalmopathy&amp;author=H+Li&amp;author=B+Wang&amp;author=Q+Li&amp;author=Q+Li&amp;author=J+Qiao&amp;volume=48&amp;issue=2&#x02013;3&amp;publication_year=2023&amp;pages=55-67&amp;pmid=37345481&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Barile L, Vassalli G, Exosomes Therapy delivery tools and biomarkers of diseases. <span><span class="ref-journal">Pharmacol Ther. </span>2017;<span class="ref-vol">174</span>:63–78.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28202367" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol+Ther&amp;title=Therapy+delivery+tools+and+biomarkers+of+diseases&amp;author=L+Barile&amp;author=G+Vassalli&amp;author=+Exosomes&amp;volume=174&amp;publication_year=2017&amp;pages=63-78&amp;pmid=28202367&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Wang Y, Chen Z, Wang T, Guo H, Liu Y, Dang N, et al. A novel CD4&#x02009;+&#x02009;CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves&#x02019; orbitopathy. <span><span class="ref-journal">Cell Mol Immunol. </span>2021;<span class="ref-vol">18</span>(3):735–45.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8027210/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33514849" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Immunol&amp;title=A+novel+CD4&#x02009;+&#x02009;CTL+subtype+characterized+by+chemotaxis+and+inflammation+is+involved+in+the+pathogenesis+of+Graves&#x02019;+orbitopathy&amp;author=Y+Wang&amp;author=Z+Chen&amp;author=T+Wang&amp;author=H+Guo&amp;author=Y+Liu&amp;volume=18&amp;issue=3&amp;publication_year=2021&amp;pages=735-45&amp;pmid=33514849&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Chen T, Chen L, Song H, Chen X, Xie R, Xia Q, et al. Clinical relevance of T lymphocyte subsets in pediatric Graves&#x02019; disease. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2020;<span class="ref-vol">33</span>(11):1425–30.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32924380" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr+Endocrinol+Metab&amp;title=Clinical+relevance+of+T+lymphocyte+subsets+in+pediatric+Graves&#x02019;+disease&amp;author=T+Chen&amp;author=L+Chen&amp;author=H+Song&amp;author=X+Chen&amp;author=R+Xie&amp;volume=33&amp;issue=11&amp;publication_year=2020&amp;pages=1425-30&amp;pmid=32924380&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR46">46. <span class="element-citation">Xia N, Zhou S, Liang Y, Xiao C, Shen H, Pan H, et al. CD4&#x02009;+&#x02009;T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves&#x02019; ophthalmopathy. <span><span class="ref-journal">Int J Mol Med. </span>2006;<span class="ref-vol">17</span>(5):911–6.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16596280" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Med&amp;title=CD4&#x02009;+&#x02009;T+cells+and+the+Th1/Th2+imbalance+are+implicated+in+the+pathogenesis+of+Graves&#x02019;+ophthalmopathy&amp;author=N+Xia&amp;author=S+Zhou&amp;author=Y+Liang&amp;author=C+Xiao&amp;author=H+Shen&amp;volume=17&amp;issue=5&amp;publication_year=2006&amp;pages=911-6&amp;pmid=16596280&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR47">47. <span class="element-citation">Liu R, Ye Z, Liu Q, Xuan M, Li R, Zhang L, et al. MicroRNA-376b is involved in the pathogenesis of thyroid-associated ophthalmopathy by regulating HAS2. <span><span class="ref-journal">Endocrine. </span>2023;<span class="ref-vol">82</span>(1):87–95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/37231239" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrine&amp;title=MicroRNA-376b+is+involved+in+the+pathogenesis+of+thyroid-associated+ophthalmopathy+by+regulating+HAS2&amp;author=R+Liu&amp;author=Z+Ye&amp;author=Q+Liu&amp;author=M+Xuan&amp;author=R+Li&amp;volume=82&amp;issue=1&amp;publication_year=2023&amp;pages=87-95&amp;pmid=37231239&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR48">48. <span class="element-citation">Qu P, Xie X, Chi J, Liu X, Liu P, Luo J, et al. Circulating Exosomal Mir-144-3p from Crohn&#x02019;s Disease patients inhibits human umbilical vein endothelial cell function by targeting FN1. <span><span class="ref-journal">Dis Markers. </span>2022;<span class="ref-vol">2022</span>:8219557.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9184168/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35692876" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dis+Markers&amp;title=Circulating+Exosomal+Mir-144-3p+from+Crohn&#x02019;s+Disease+patients+inhibits+human+umbilical+vein+endothelial+cell+function+by+targeting+FN1&amp;author=P+Qu&amp;author=X+Xie&amp;author=J+Chi&amp;author=X+Liu&amp;author=P+Liu&amp;volume=2022&amp;publication_year=2022&amp;pages=8219557&amp;pmid=35692876&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR49">49. <span class="element-citation">Chang TK, Wang YH, Kuo SJ, Wang SW, Tsai CH, Fong YC, et al. Apelin enhances IL-1&#x003b2; expression in human synovial fibroblasts by inhibiting mir-144-3p through the PI3K and ERK pathways. <span><span class="ref-journal">Aging. </span>2020;<span class="ref-vol">12</span>(10):9224–39.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7288923/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32420902" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aging&amp;title=Apelin+enhances+IL-1&#x003b2;+expression+in+human+synovial+fibroblasts+by+inhibiting+mir-144-3p+through+the+PI3K+and+ERK+pathways&amp;author=TK+Chang&amp;author=YH+Wang&amp;author=SJ+Kuo&amp;author=SW+Wang&amp;author=CH+Tsai&amp;volume=12&amp;issue=10&amp;publication_year=2020&amp;pages=9224-39&amp;pmid=32420902&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR50">50. <span class="mixed-citation">Chen C, Zhao C, Gu C, Cui X, Wu J. MiRNA-144-3p inhibits high glucose induced cell proliferation through suppressing FGF16. Biosci Rep. 2019;39(7). <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6658725/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31292167" ref="reftype=pubmed&amp;article-id=11157872&amp;issue-id=452086&amp;journal-id=214&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]<link class="expression-of-concern" pmcaccid="PMC7332675" /></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Journal of Translational Medicine</span> are provided here courtesy of <strong>BMC</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11157872/pdf/12967_2024_Article_5263.pdf" class="int-view">PDF (9.5M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11157872/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11157872/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11157872" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="4ZEK4HVkh20vg3GPbL6vElI49FUn0E3DaV3Rx7O7F7AZ8eIySrfDXBf5lp59H4fI">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F&amp;text=Plasma%20exosomes%20from%20patients%20with%20active%20thyroid-associated%20orbitopathy%20induce%20inflammation%20and%20fibrosis%20in%20orbital%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11157872%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11157872/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38849907/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38849907/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11157872/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11157872/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC11157872/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
